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The cornea is an avascular and transparent tissue, refracting light towards the retina. Corneal 
collagen fibers run parallel to each other and organize into stacked lamellae. Corneal ectasia due to 
diseases such as keratoconus causes disruption of the organized ultrastructure, significantly 
impairing vision. In more severe disease conditions, or when the cornea stroma is damaged, 
blindness can occur as a result of tissue fibrosis requiring corneal transplantation. This dissertation 
addresses the need for development of safer and more effective treatments for corneal disease and 
transplantation. 
An ex vivo corneal ectasia model was developed to ascertain efficacy of novel therapies for corneal 
ectasia. Reinforcement of corneal biomechanics, thermal stability, restoration of damaged corneal 
stromal ultrastructure and gene expression following treatment with tissue derived extracellular 
matrix (ECM) microparticles was investigated. ECMs significantly improve corneal biomechanics, 
reduce inflammation and maintain healthy keratocyte phenotype. Concurrently, functionalized 
chondroitin sulfate (CS) proteoglycans which were used to chemically crosslink the corneal stroma 
promoted lamellar and fibrillar stabilization, restored stiffness and lowered proinflammatory gene 
expression, compared to the conventional clinical treatment. These therapies indicate that 
harnessing biological and bio-inspired crosslinking techniques allow for equally effective, and 
significantly safer corneal ectasia treatments. 
Further, to engineer biosynthetic corneal transplants, collagen self-assembly processes were 
modulated using cyclodextrins (CD) as artificial chaperones to create biomaterials that mimic 
native corneal structure. Combination of βCD with collagen (Col) gelation and vitrification 
produced materials with aligned fibers and lamellae that were mechanically robust and transparent. 
Molecular analysis revealed CD formed reversible interactions with hydrophobic amino acids on 
the collagen chains. To translate in vivo, custom molds for gelation and vitrification were 
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engineered to create βCD/Col implants with corneal curvature which were implanted in rabbits. 
Moreover, fibrillogenesis and collagen gelation was modulated though controlled ammonia 
exposure conditions. Changes in duration of exposure and points of surface contact were able to 
confer control over the fibrillar structures formed. Use of straightforward gelation techniques and 
inexpensive artificial chaperones could potentially be used to manipulate collagen assembly to 
engineer biomaterials with advanced structural and functional properties. 
 
Readers: 
Professor Jennifer Elisseeff 





First and foremost, I would like to express my gratitude to my advisor, Professor Jennifer Elisseeff 
for her invaluable advice and guidance, and my academic advisor Professor Hai-Quan Mao for his 
constant support and help. I am also deeply appreciative of Professor Anirudha Singh, Professor 
Kalina Hristova, and Dr. Oliver Schein for their invaluable comments and constructive criticism as 
members of my thesis defense committee.  
A special thanks to Dr. Marcos-Garza Madrid, Dr. Qiongyu Guo, Dr. Xiaokun Wang, Dr. Jemin J. 
Chae in the Elisseeff lab who all helped in mentoring and teaching me in the beginning of my 
graduate studies, and provided me with assistance and advice whenever I needed it. I would also 
like to extend a heartfelt appreciation to all past and present members of the Elisseeff lab during 
my time as a graduate student, for their technical, intellectual and moral support, all of which 
contributed to my success and the development of my analytical and scientific skills. 
I am also very grateful to Dr. Morgana Trexler, Professor Stellacci, Dr. Tripp, Professor Amzel, 
Barbara Smith, Michael Delannoy and Evangelia Athanasopoulou who have helped both directly 
and indirectly with training and running several specialized equipment. A very special gratitude 
goes out to Tony Lee, Dr. Derek Duan, Jack England, Priscilla Carbajal and Kylie Matsumoto at 
Eyegenix, LLC for their counsel on product development, quality and translation of the research.  
I also wish to express my gratitude to Research to Prevent Blindness, the US Department of 
Defense, and the Wilmer Eye Institute, who helped fund this research. I am also grateful to the 
faculty and staff of the Translational Tissue Engineering Center, and Department of Materials 
Science and Engineering at the Johns Hopkins University for their unfailing support, 
encouragement, financial means and laboratory facilities that permitted my research. 
Finally, last but by no means the least, I am thankful for my friends and family – especially my 
parents, siblings, and my wife – for their patience, encouragement, and boundless love during the 
course of my studies.  
v 
 
Table of Contents 
Abstract .............................................................................................................................. ii 
Acknowledgements .......................................................................................................... iv 
Table of Contents .............................................................................................................. v 
List of Tables .................................................................................................................... ix 
List of Figures .................................................................................................................... x 
1. Introduction ............................................................................................................ 1 
1.1. Corneal Ectasia Progression and Current Clinical Treatments ........................................ 3 
1.2. Complex Collagen Organization in Corneal Stroma ....................................................... 4 
1.3. Current Options for Keratoplasty and Competing Strategies. ......................................... 5 
1.4. Controlled Self-assembly of Collagen through Artificial Chaperones ............................ 6 
1.5. Cornea-mimetic Biomaterial Structure and Resulting Properties. ................................... 8 
1.6. Collagen Biomaterial Processing to Create Vitrigels. ...................................................... 8 
1.7. Chaperone Molecules to Enhance Transparency ............................................................. 9 
2. Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in 
membranes for corneal repair ....................................................................................... 10 
2.1. Introduction .................................................................................................................... 10 
2.2. Materials and methods ................................................................................................... 12 
2.2.1. Preparation of collagen membranes ....................................................................... 12 
2.2.2. Transmission electron microscopy (TEM)............................................................. 13 
2.2.3. Keratocytes isolation and culture ........................................................................... 14 
2.2.4. AlamarBlue assay .................................................................................................. 14 
2.2.5. Quantification of cellular morphology ................................................................... 15 
2.2.6. Gene expression analysis ....................................................................................... 16 
2.2.7. Statistics ................................................................................................................. 16 
2.3. Results ............................................................................................................................ 16 
2.3.1. Collagen vitrigel preparation and nanoarchitecture ............................................... 16 
2.3.2. Morphology and proliferation of sub cultured keratocytes .................................... 18 
2.3.3. Keratocyte gene expression dependence on collagen nanoarchitecture ................. 19 
2.4. Discussion ...................................................................................................................... 20 
2.5. Conclusion ..................................................................................................................... 23 
3. Tissue Derived Extracellular Matrix stabilizes ectatic corneal biomechanics 
and ultrastructure ........................................................................................................... 31 
3.1. Introduction .................................................................................................................... 31 
vi 
 
3.2. Materials and Methods ................................................................................................... 32 
3.2.1. ECM conditioned medium preparation .................................................................. 32 
3.2.2. Ectatic corneal (KC) culture in ECM conditioned media ...................................... 33 
3.2.3. Optical coherent tomography (OCT) ..................................................................... 33 
3.2.4. Transmission electron microscopy ......................................................................... 33 
3.2.5. Image analysis: ....................................................................................................... 34 
3.2.6. Tensile test ............................................................................................................. 34 
3.2.7. Differential scanning calorimetry (DSC) ............................................................... 34 
3.2.8. Gene expression ..................................................................................................... 35 
3.2.9. Statistical Analysis ................................................................................................. 36 
3.3. Results ............................................................................................................................ 36 
3.3.1. Corneal structural changes after ECM treatment ................................................... 36 
3.3.2. Corneal mechanical properties and thermal stability after ECM treatment ........... 37 
3.3.3. Gene expression ..................................................................................................... 38 
3.4. Discussion ...................................................................................................................... 38 
3.5. Conclusion ..................................................................................................................... 41 
4. Chondroitin Sulfate-based Biocompatible Crosslinker Restores Corneal 
Mechanics and Collagen Alignment .............................................................................. 47 
4.1. Introduction .................................................................................................................... 47 
4.2. Methods ......................................................................................................................... 49 
4.2.1. Synthesis of Amine-Reactive Chondroitin Sulfate ................................................ 49 
4.2.2. Corneal Ectatic Model and Crosslinking ............................................................... 49 
4.2.3. CS-NHS Penetration into Corneal Tissue .............................................................. 50 
4.2.4. Corneal Swelling Ratios ........................................................................................ 50 
4.2.5. Transmission Electron Microscopy (TEM) ........................................................... 51 
4.2.6. Live-Dead Staining ................................................................................................ 51 
4.2.7. Hematoxylin and Eosin (H&E) Staining ............................................................... 52 
4.2.8. Tensile Testing ....................................................................................................... 52 
4.2.9. Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction ........ 52 
4.2.10. Statistical Analysis ................................................................................................. 53 
4.3. Results ............................................................................................................................ 54 
4.3.1. CS-NHS Penetration into the Cornea ..................................................................... 54 
4.3.2. Impact of CS-NHS Crosslinking on Corneal Swelling and Biomechanics ........... 54 
4.3.3. Normal Corneal Ultrastructure After Crosslinking ................................................ 55 
4.3.4. Cell Viability in CS-NHS Crosslinking ................................................................. 55 
4.3.5. Ectatic Corneal Morphologies and Biomechanics Following CS-NHS Crosslinking 
  ............................................................................................................................... 56 
vii 
 
4.3.6. Keratocyte Gene Expression After Crosslinking ................................................... 57 
4.4. Discussion ...................................................................................................................... 57 
4.5. Conclusions .................................................................................................................... 60 
5. Artificial chaperone driven collagen self-assembly to engineer a biomimetic 
cornea implant ................................................................................................................. 69 
5.1. Introduction .................................................................................................................... 69 
5.2. Methods ......................................................................................................................... 71 
5.2.1. Synthesis of CD/Col corneal implants via vitrification ......................................... 71 
5.2.2. Electron microscopy (EM) ..................................................................................... 71 
5.2.3. Atomic Force Microscopy (AFM) ......................................................................... 72 
5.2.4. Physical characteristics measurements .................................................................. 72 
5.2.5. Biophysical studies on mechanism of CD/collagen binding and ultrastructure 
formation ............................................................................................................................... 73 
5.2.6. Cell culture, PCR and biological assays ................................................................ 75 
5.2.7. In vivo surgical procedures and post-operative care .............................................. 76 
5.2.8. Statistical analysis .................................................................................................. 77 
5.2.9. Data availability ..................................................................................................... 77 
5.3. Results and Discussion .................................................................................................. 78 
5.3.1. CD artificial chaperones modulate collagen self-assembly ................................... 78 
5.3.2. βCD molecular interactions with collagen ............................................................. 81 
5.3.3. βCD/Col biomimetic cornea compatibility and surgical performance ................... 83 
5.3.4. Artificial chaperones for controlling collagen assembly and development of 
functional biomimetic implants ............................................................................................. 85 
6. A versatile approach to modulate collagen fibrillogenesis to alter optical and 
biological properties of corneal implants. ..................................................................... 96 
6.1. Introduction .................................................................................................................... 96 
6.2. Methods ......................................................................................................................... 99 
6.2.1. AMC vitrigel preparation ....................................................................................... 99 
6.2.2. Second Harmonic Generation Microscopy .......................................................... 100 
6.2.3. Light Transmission .............................................................................................. 100 
6.2.4. Scanning Electron Microscopy ............................................................................ 100 
6.2.5. Tensile Testing ..................................................................................................... 100 
6.2.6. Ex vivo migration model for tracking corneal reepithelialization ....................... 101 
6.2.7. In vivo experiments .............................................................................................. 101 
6.2.8. Histology .............................................................................................................. 102 
6.3. Results and Discussion ................................................................................................ 102 
6.3.1. Using ammonia to modulate collagen fibrillogenesis .......................................... 102 
viii 
 
6.3.2. Type I Collagen source and processing affect AMC vitrigel characteristics ....... 102 
6.3.3. Evidence of layering and alignment using Second Harmonic Generation 
microscopy ........................................................................................................................... 103 
6.3.4. Ultrastructural and mechanical characterization .................................................. 104 
6.3.5. Preliminary development of an ex vivo model for corneal reepithelialization .... 105 
6.3.6. Guiding collagen fibrillogenesis via physical nucleation cues ............................ 106 
6.3.7. In vivo surgical implantation of AMC material ................................................... 106 
6.4. Conclusions .................................................................................................................. 107 
References ...................................................................................................................... 116 





List of Tables 
Table 1.1 Strengths and weaknesses of emerging approaches to create biosynthetic corneas ........ 6 
Table 1.2 Comparison of emerging biosynthetic corneal technologies with native cornea. ........... 7 
Table 2.1 RT-PCR Primer Sequences. .......................................................................................... 24 
Table 3.1 Gene primers used to assess gene expression in ECM treated corneas. ........................ 35 
Table 4.1 Ultrastructural analysis of corneas before and after crosslinking ................................. 62 





List of Figures 
Figure 2.1 Collagen vitrigel preparation and alignment: (A) three-step procedures, and (B) 
TEM image of CV central portions showing 2D alignment of matured collagen fibrils by 
vitrification. .................................................................................................................................... 25 
Figure 2.2 TEM images of CVs and collagen fibril analysis: (A-D) Transverse plane, (E-H) 
coronal plane, and (I-K) collagen fibril analyses. Four CVs were used: (A, E) CV 5°C, 0.5 wk, 
(B, F) CV 5°C, 2 wk, (C, G) CV 39°C, 1 wk, and (D, H) CV 39°C, 2 wk. Collagen fibril analyses 
include (I) fibril diameter, (J) d-periodicity (banding), (K) fibril density. The TEM samples were 
obtained from the center portions of the collagen membranes. Collagen fibrils with large bending 
curvature were indicated by triangle. The error bars in (I, J) represent the standard deviation of 
the mean. Scale bar in (A-H): 200 nm. ***p < 0.001. ................................................................... 26 
Figure 2.3 Keratocyte morphologies cultured on CVs using two different culture media: (A-
D) serum-free culture medium, and (E-H) culture medium with 10% FBS. Four cell culture 
substrate conditions were used: (A, E) TCP control (B, F) CV 39°C, 1 wk, (C, G) CV 39°C, 2 wk, 
and (D, H) CV 39°C, 8 wk. Pinning points in cell extensions were highlighted by triangle. Scale 
bar: 200 mm. .................................................................................................................................. 27 
Figure 2.4 Morphological analysis of keratocytes cultured on CV vitrified at 39°C using 
serum-free medium. (A-C) A keratocyte example cultured on CV (39°C, 8 wk) (A) with cellular 
contour identified in (B) and morphological skeleton acquired in (C). Based on cellular contour 
and skeleton, the dependence of keratocyte morphologies on CV vitrification processing time was 
examined (D-I), including cell size (D), total number of protrusions (E), mean length of 
protrusions (F), primary protrusion number (G), secondary protrusion number (H), and the ratio 
of secondary to primary protrusions (I). The error bars in (D-I) represent the standard deviation of 
the mean. Keratocytes cultured on the TCP were tested as a control. All statistical differences 
against the TCP control are indicated. *p < 0.05, **p < 0.01, ***p < 0.001. ................................ 28 
Figure 2.5 Effects of CV processing conditions on the proliferation of primary keratocytes 
cultured in serum-free medium. The CVs were processed from 0.5 wk up to 2 wk at two 
different temperatures (5°C and 39°C). The proliferation of keratocytes at Day 4 relative to Day 2 
was assessed using an AlamarBlue assay and normalized by the TCP control. *p < 0.05, **p < 
0.01. ............................................................................................................................................... 29 
Figure 2.6 Gene expression of keratocytes fibroblasts seeded on CVs processed under 
different conditions and cultured in serum-based medium. All statistical differences are 
indicated with the ones against TCP control showing above each bar, and the others comparing 
CV groups portrayed on lines. *p < 0.05, **p < 0.01, ***p < 0.001. ............................................ 30 
Figure 3.1 Schematic demonstrating ECM treatment and effect on cornea ultrastructure. 
Enzymatically induced corneal weakening and degradation to simulate corneal ectasia followed 
by treatment of KC eyes to various ECM conditioned media to demonstrate restorative effects of 
ECM. .............................................................................................................................................. 42 
Figure 3.2 Gross changes observed following ECM treatment. A) Gross pictures of rabbit 
corneas subjected to various ECMs and the effect of treatments on clarity of the corneas. B) OCT 
images to determine changes in thickness and hyper-reflection of the corneas post-treatment..... 43 
Figure 3.3 Changes in fibrillar packing of corneal collagen. Visualization of collagen fibril 
density of unwounded control corneas, enzymatically degradaded KC corneas and ECM treated 
KC corneas through transmission electron microscopy,with accompanying graph showing results 
of calculation of fibril diameter distribution after each treatment. ................................................ 44 
Figure 3.4 Influence of ECM treatment of physical and thermal properties of cornea. A) 
Visualization of collagen fibril density of unwounded control corneas, enzymatically degradaded 
KC corneas and ECM treated KC corneas through transmission electron microscopy,with 
xi 
 
accompanying graph showing results of calculation of fibril diameter distribution after each 
treatment. ....................................................................................................................................... 45 
Figure 3.5 Gene expression of keratocytes after crosslinking. Inflammatory marker Tnfα, 
keratocyte markers Aldh, Keratocan and Biglycan were evaluated among normal, KC and ECM 
treated corneas. N=6 in each group, * refers to p<0.05 compared to normal corneas, and # refers 
to p<0.05 compared to KC corneas. ............................................................................................... 46 
Figure 4.1 Chemical design and penetration of CS crosslinker through the cornea. (A) CS-
NHS is labeled with TARMA dye by covalently reacting with amine groups in TARMA-(PEO)3-
amine to track penetration depth. (B) Corneal explants were immersed in varying concentrations 
of fluorescently labelled crosslinker for 30 and 60 min to visualize CS-NHS penetration. Image 
analysis quantified the (C) intensity at 100 µm depth (related to concentration) and (D) depth of 
fluorescently labeled CS-NHS crosslinker. The CS-NHS crosslinker penetrated approximately 
250-400 µm into the corneal tissue after 60 min of exposure. ....................................................... 63 
Figure 4.2 Normal corneal swelling and biomechanical properties after crosslinking.  (A) 
CS-NHS reacts with collagen molecules and forms a strong covalent network. (B) The decrease 
of swelling ratio was in direct response to crosslinking time and CS-NHS concentration after 30 
min and 60 min of crosslinking; (C) the enhancement of corneal biomechanics was demonstrated 
with Young’s modulus increase after 60 min of crosslinking. N=6 in each group and *p<0.05 
compared to control corneas. ......................................................................................................... 64 
Figure 4.3 Normal corneal ultrastructures after crosslinking. Crosslinking time and 
crosslinker concentration have significant impacts on corneal ultrastructure. Collagen diameter 
and fibril density increased gradually with the increase of crosslinking time and concentration. . 65 
Figure 4.4 Cell viability after crosslinking. Keratocyte viability after CS-NHS crosslinking was 
evaluated with live-dead staining. White arrows indicate corneal epithelial cells, dashed arrows 
indicate keratocytes, and red arrows indicate apoptotic cells. No significant cell apoptosis 
occurred after 60 min of crosslinking. ........................................................................................... 66 
Figure 4.5 Ectatic corneal morphology and biomechanics after crosslinking. (A) Histological 
images of corneas undergoing different treatments, and (B) TEM images at 9700x magnification 
of KC corneas after crosslinking. Images from left to right represent normal, enzyme treated 
(KC), UV crosslinked KC (KC-UV), and 5 mg/ml CS-NHS treated KC (KC-CS5) corneas. (C) 
Young’s modulus and (D) stress-strain curves of normal and ectatic corneas after crosslinking. 
N=6 in each group, * refers to p<0.05 compared to normal corneas, and # refers to p<0.05 
compared to KC corneas. ............................................................................................................... 67 
Figure 4.6 Gene expression of keratocytes after crosslinking. Inflammatory markers Tnfα and 
Mmp9, keratocyte markers Aldh and Biglycan were evaluated among normal, KC and 
crosslinked corneas. N=6 in each group, * refers to p<0.05 compared to normal corneas, and # 
refers to p<0.05 compared to KC corneas...................................................................................... 68 
Figure 5.1 Cyclodextrin artificial chaperones modulate fibril formation and alignment in 
vitrified collagen cornea substitutes via interactions with collagen. a) Schematic 
demonstrating cyclodextrin-collagen binding, ultimately influencing collagen ultrastructural 
organization and spacing. b) General chemical structure of beta-cyclodextrin depicting the 7-
sugar cyclic oligosaccharide with modifiable functional groups (-R).  c) Gross image of 500 µm 
thickness implants manufactured using βCD-Suc and collagen to demonstrate optical clarity. d) 
Evidence of macroscale lamellar structures in the implants as evidenced by careful peeling of 
individual layers. ............................................................................................................................ 86 
Figure 5.2 Screening CDs with varying size and functionality for ability to control collagen 
self-assembly. a) Molecular structures of the 6-sugar cyclic oligosaccharide α cyclodextrin, the 7-
sugar cyclic oligosaccharide β cyclodextrin, and the 8-sugar cyclic oligosaccharide γ 
cyclodextrin. R- represents modifiable functional groups. b) Transmission electron microscopy of 
cross sections of several CD/Col materials with different cyclodextrins, during initial screening 
process to determine notable differences in collagen fibril formation and organization. Scale bar = 
xii 
 
500 nm c) Scanning electron microscopy (left) and transmission electron microscopy (right) 
images to elucidate ultrastructures of αCD/Col, αCD-Suc/Col and γCD/Col respectively. Scale 
bar = 100 nm .................................................................................................................................. 87 
Figure 5.3 Cyclodextrin functional groups define collagen fibril organization, transparency 
and mechanical properties. a) Vitrigels manufactured by mixing equal volumes of collagen and 
CD-buffered solution causing gelation and micro-fibrillar assembly followed by fibril growth and 
reorganization during controlled dehydration (vitrification). b) Transmission electron microscopy 
and scanning electron microscopy of Col, βCD, and βCD-Suc and native rabbit cornea, to 
demonstrate effect of CD functionality on collagen ultrastructure organization. Scale bar = 500 
nm c) Light transmission over visible light spectrum of vitrigel formulations (normalized to 400 
µm) with and without incorporation of cyclodextrins, d) Young’s modulus and strain at break 
measurements to monitor tensile properties of vitrigels following cyclodextrin incorporation. e) 
Oscillatory rheological properties of vitrigel formulations with cyclodextrin functionalization. f) 
Differential scanning calorimetry thermograms to determine thermal stability of vitrigels 
following incorporation of CD. Data are means ± SD, n ≥ 3 (representative of at least two 
independent experiments), analysis of variance (ANOVA) with Bonferroni’s post-test [(d) and 
(e)]: ***P < 0.0001, **P < 0.001, *P < 0.01 compared against Col unless otherwise specified. .. 88 
Figure 5.4 Further physical characterization of selected CD/Col materials. a) Swelling ratio 
determined as a ratio between fully hydrated vitrigel weight and weight following lyophilization. 
b) Theoretical collagen concentration in final vitrified product. c) Light transmission over visible 
light spectrum of vitrigel formulations with and without incorporation of cyclodextrins after 
initial screening, normalized to 400 µm. d) Light transmission values of the materials at 550 nm. 
e) Tensile stress-strain curves of vitrigel strips to evaluate elastomeric behavior following CD 
incorporation. f) Simultaneous comparisons of elastic modulus and strain at break for each 
vitrigel formulation to assess viability as corneal substitutes. g) Oscillatory rheological analyses 
of CD incorporated vitrigels to determine viscoelastic properties, h) DSC thermograms to 
quantify thermal stabilization following incorporation of various CD molecules. Data are means ± 
SD, n ≥ 3 (representative of at least two independent experiments), analysis of variance 
(ANOVA) with Bonferroni’s post-test: ***P < 0.0001, **P < 0.001, *P < 0.01, compared against 
Col unless otherwise specified. ...................................................................................................... 89 
Figure 5.5 Collagen-cyclodextrin molecular interactions and effect on fibril formation. a) 
Circular dichroism spectroscopy among groups to demonstrate changes in thermal stability 
following molecular interactions between soluble collagen and βCD, b) CD spectrum of collagen 
triple helix with and without CD at a temperature of 5ºC. c) Shift in UV-visible light spectrum 
absorbance peak following incorporation of βCD and βCD-Suc into soluble collagen. d) 
Frequency change associated with βCD and βCD-Suc deposition and binding to collagen coated 
substrate via QCM analyses (frequency overtone n=5). e) Quantification of binding affinity of 
βCD with collagen via ITC at 20ºC. f) Schematic showing interaction of collagen hydrophobic 
groups with hydrophobic inner core of βCD and chemical structure, g) Incorporation of βCD-Suc 
in collagen involves additional interaction of the highly hydrophilic succinyl side chains and 
βCD-Suc chemical structure. ......................................................................................................... 90 
Figure 5.6 Selected CD/collagen molecular interactions and consequent release from bulk 
material. a) Circular dichroism spectroscopy demonstrates temperature shifts when following 
interactions of collagen with different CDs. b) CD spectrum signal of the characteristic collagen 
triple helix curve is suppressed to various levels with different CDs indicating potentially limited 
fibril formation. c) CD interacts with collagen aromatic groups causing a blue-shift in wavelength 
and an increase in absorbance peaks, observed in the UV-visible wavelength spectrum. d) 
Majority of βCD and βCD-Suc release from vitrified implants on rehydration, indicating stable 
structural/chemical changes caused by CDs during vitrification. .................................................. 91 
Figure 5.7 Topography, amplitude and phase shift response of cornea mimetic material 
observed by AFM for dried and rehydrated samples. Hydrophilic areas (indicated by arrows) 
xiii 
 
close and around collagen fibers can be observed in the phase shift channel of the dried samples. 
These areas, present only in the samples with CD addition, cannot be observed in the equivalent 
rehydrated samples. Scale bar 200 nm. .......................................................................................... 92 
Figure 5.8 Cellular compatibility and surgical in vivo performance of biomimetic collagen-
CD implants. a) Proliferation of primary rabbit corneal epithelial cell on CD/Col materials and 
staining for K14 (red) and DAPI (blue) on βCD/Col vitrigels. Scale bar = 20 µm b) Cross-section 
of in vitro epithelial cell culture on βCD/Col with K14 and DAPI staining, c) Custom molds used 
for manufacturing implants with desired curvature. d) Lenticularly shaped βCD/Col corneal 
implants with curvature of healthy cornea. e) qPCR with epithelial cell culture on vitrigels to 
determine regulation of genetic markers CX43, K3 and P63. f) Schematic of in vivo implantation 
of corneal implant and affixation using interrupted sutures. g) Gross images of the in vivo ocular 
surgery in the rabbit model over 31 days and fluorescein staining (under blue light) to monitor 
progress of reepithelialization over βCD/Col implant. Yellow staining under blue light indicates 
regions of the implant without epithelial cell coverage. h) Histological analysis of sections stained 
using Masson’s Trichrome to visualize implant after 14 days. Scale bar = 100 µm. i-j) 
Immunostaining for laminin (red) and DAPI (blue) in peripheral and central wound regions. 
Laminin proteins are expressed by epithelial cells after maturation. Scale bar = 50 µm. Data are 
means ± SD, n = 6 (representative of at least two independent experiments), analysis of variance 
(ANOVA) with Bonferroni’s post-test [(e)]: ***P < 0.0001 ......................................................... 93 
Figure 5.9 Immunocytochemistry and qPCR of rabbit corneal epithelial cells grown on 
several different CD/Col substrates with staining for K14 counterstained with DAPI as 
indicated for a) αCD/Col, b) βCD/Col, c) γCD/Col, d) αCD-Suc/Col, e) βCD-Suc/Col, f) Col 
only, g) Tissue culture treated polystyrene (TCPS). Scale bar: 20 μm. h) qPCR of key epithelial 
markers CX43, K3, and limbal stem cell marker P63. Data are means ± SD, n = 6 (representative 
of at least two independent experiments), analysis of variance (ANOVA) with Bonferroni’s post-
test [(e)]: ***P < 0.0001 ................................................................................................................ 94 
Figure 5.10 In vivo surgical compatibility of βCD/Col implants in rabbits. a) Implantation of 
CD vitrigels as corneal implants via anterior lamellar keratoplasty using interrupted sutures, and 
observation of healing process (gross images) and reepithelialization (using fluorescein dye, 
under blue light) over 31 days. b) Histological sectioning and staining using Masson’s Trichrome 
to demonstrate survival and integration of the implants. Scale bar = 100 µm. .............................. 95 
Figure 6.1 Schematics depicting ammonia mediated collagen gelation. a) Laboratory setup for 
controlled ammonia exposure on collagen materials. b) Fibril formation during ammonia 
penetration and gelation during the process of manufacturing AMC vitrigels. c) Gross picture of 
35 mm diameter, 500 µm AMC vitrigel. ..................................................................................... 108 
Figure 6.2 AMC vitrigel formulations with different collagen sources demonstrate 
differences in physical characteristics. a) Transparency of collagen vitrigels from different 
collagen sources, b) thermograms depicting collagen stability of vitrigels from collagen source.
 ..................................................................................................................................................... 109 
Figure 6.3 Duration of ammonia exposure causes changes in ultrastructure and optical 
characteristics of AMC materials. a) Second harmonic generation microscopy Z-stack imaging 
of AMC vitrigels with different exposure times, b) Transparency of AMC vitrigels change 
dramatically with different durations of ammonia exposure. Gelation times were constant at 30 
min. .............................................................................................................................................. 110 
Figure 6.4 Ultrastructural changes and tensile properties of AMC with varying exposure 
times. a) SEM images of AMC vitrigels demonstrating fibrillar surface topography, b) Young’s 
modulus and Strain at Break for various AMC materials. c) Representative stress-strain curves for 
AMC materials. ............................................................................................................................ 111 
Figure 6.5 Development of ex vivo culture model for tracking corneal reepithelialization. a) 
Schematic depicting ex vivo corneal surgery and implantation of AMC materials, b) Fluorescein 
dye staining and imaging under blue light to track epithelial wound area (in yellow-green). ..... 112 
xiv 
 
Figure 6.6 Histology and immunofluorescence of ex vivo AMC corneal cultures. a) H&E 
staining of corneal sections to demonstrate multicellular epithelialization, b) Immunofluorescence 
marker expression for nucleus (DAPI), keratin-14 (K14) and tight junction protein (ZO-1) in 
AMC materials to track epithelial cell maturation over 24 h, 48 hand 72 h. ............................... 113 
Figure 6.7 Micropatterning collagen ultrastructures on AMC materials. a) Micropattern 
mesh used to initiate guided fibril formation, b) SHG imaging of micropatterned AMC materials 
to visualize collagen fibril formation patterns, c) Corneal epithelial cell maturation with 
immunofluorescence markers K14, ZO-1 and DAPI on micropatterned AMC material at 72 hr.
 ..................................................................................................................................................... 114 
Figure 6.8 In vivo implantation of AMC vitrigels in rabbit model. a) Custom-made PDMS 
molds to manufacture lenticular AMC materials, b) Implanted AMC materials tracked over 31 
days via anterior lamellar keratoplasty through gross images and fluorescein staining, c) 
Masson’s Trichrome histology to observe integration of the implant, d) immunohistochemistry to 





The cornea is the transparent, anterior-most ocular tissue, with a highly organized extracellular 
matrix. Normal cornea tissue structure provides a clear and mechanically robust surface for the 
outermost segment of the eye. When the cornea is damaged, due to injury or disease, loss of vision 
occurs.  Diseases such as Keratoconus are characterized by progressive thinning and ectasia of the 
cornea, creating a cone-shaped cornea, severe stigmatism, and visual impairment [1].  Up to 20% 
of keratoconus patients require keratoplasty, or corneal transplantation.  A number of treatment 
modalities have been developed to reduce corneal deformation and correct vision.  Corneal 
crosslinking via UV light is a popular strategy that enhances mechanical properties of the cornea 
and potentially reduce disease progression [2].  However, little is known about the ultrastructural 
changes that occur during crosslinking, therapeutic optimization, and long-term consequences.  
In case of deeper corneal stromal wounds, the cornea stroma cannot repair itself; instead it 
undergoes a scarring process that limits transparency and impairs vision. In the U.S. alone, total 
medical costs related to injuries and burns to the eye resulting in visual disability in patients, was 
$1.3 billion in 2013, not including corneal defects and disease[3]. Keratoplasty is the most frequent 
clinical intervention. Although donor tissue is not in short supply in the US, demand is steadily 
increasing. Total demand for corneal graft tissue in the US has seen a 45% increase from 52,487 in 
2008 to 76,431 in 2014[4]. several barriers limit the effectiveness of keratoplasty. In the U.S., the 
costs of tissue are high and the shelf life of donor tissue in storage media is limited. While implant 
rejection rate for first-time transplant recipients is relatively low at 10% without 
immunosuppression or antigen matching, rejection rates climb to as high as 70% for high-risk 
patients with vascularization or previous transplant rejection history[5,6,7,8]. These patients need 
another option for corneal replacement. 
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In developing countries, corneal blindness is even more prevalent, and the availability of quality 
donor tissue is extremely limited. In certain parts of Africa, almost 90% of all blindness is caused 
by underlying corneal pathology[9]. A recent review estimated that globally, only 1 cornea is 
available for 70 that are needed[10]. The pool of donor tissue is decreasing globally owing to the 
increased rates of surgery for refractive correction. One review concluded, “Efforts to encourage 
cornea donation must continue in all countries, but is also essential to develop alternative and/or 
complementary solutions, such as corneal bioengineering.”[10] Rejection and mechanical failure 
(non-immunologic loss of corneal clarity over time) are common, especially for younger patients 
and those with ocular comorbidities[11]. In both developed and developing nations, alternative 
options for preventing corneal disease progression and repairing corneal injury and scarring are 
needed.  
In the following dissertation, the author addresses corneal disease and injury treatment with 
multiple biologically inspired strategies. Chapter 2 of this thesis aims to understand and modulate 
fibrillogenesis in collagen gels to study changes in physical, thermal and biological characteristics, 
thereby controlling corneal stromal phenotype when based on collagen fibrillar nanoarchitecture of 
the cell substrate. In Chapter 3 and 4, the thesis explores the development of bio-inspired corneal 
ectasia therapies. These therapies aim to increase safety of treatment modalities while maintaining 
the level of crosslinking efficacy seen in current treatment options. These sections involve the 
development of ex vivo ectasia model followed by microparticle ECM treatment of corneas in 
Chapter 3 and chondroitin-sulfate proteoglycan crosslinking in Chapter 4. These methods 
efficiently crosslink the ex vivo corneas and were observed to be safer than the traditional UV 
crosslinking methods currently used in the clinic.  
Chapter 5 describes the design and development of bio-mimetic biomaterial collagen implant that 
replicates the native cornea structure. Owing to the knowledge gained from Chapter 2 about cell 
behavior on collagen substrates, and from Chapter 3/4 regarding effects of proteoglycan 
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interactions with collagen, a biomaterial with artificial chaperones to direct collagen fibril 
formation and organization was envisioned. The cornea mimetic materials are formulated and 
optimized for mechanical, thermal, optical characteristics. Biophysical and ultrastructural studies 
of biomaterials depict the control and unique structural arrangement from controlled self-assembly 
of the collagen. Further, we establish biocompatibility and evaluate the in vivo performance of the 
biomaterials in a corneal defect model.  
Chapter 6 contends with another unique collagen-based biomaterial formulation, wherein directed 
modulation of collagen fibrillogenesis is achieved through ammonia exposure. Full 
characterization and implantation of the resulting biomaterials in vivo is successfully undertaken.  
1.1. Corneal Ectasia Progression and Current Clinical Treatments 
The cornea has a unique matrix structure that allows it to have clarity for vision and mechanical 
strength to protect the eye and support vision acuity.  The matrix is composed of collagen fibrils 
that are highly organized into lamellae.  In addition, proteoglycans (PGs) intermingle to organize 
and provide additional mechanical properties to the meta-structure [12].  This extracellular matrix 
structure influences the biological properties and behavior of keratocytes that populate the corneal 
stroma.  Keratoconus is a disease where the corneal stroma matrix becomes disrupted and loses this 
fine structural organization [13]. Clinically, keratoconic corneas (KCs) are treated by riboflavin 
(RF)-catalyzed crosslinking of the corneal stroma under exposure of long-wavelength ultraviolet 
light (UVA). In normal corneas, the crosslinking reactions were reported to be carbonyl-based, and 
mainly happened within the single collagen fibrils and the PG core proteins [14].  A limited number 
of linkages are present between collagen fibrils and the PG [15], which can be explained by the 
dependence of the crosslinking reaction on the availability of functional groups within a distance 
of 5-10 nm [16]. This distance is shorter than the fibril spacing in normal corneas and it can be 
anticipated that in the KC corneas, the frequency of natural crosslinking reactions will be even 
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more negatively impacted due to the disrupted collagen fibrillar organization and the dysfunctional 
PGs between the collagen fibrils. However, no systematic study has been reported to understand 
the changes in the diseased cornea in response to the crosslinking reaction as compared to the 
normal cornea.  Moreover, significant reduction of keratocyte density in KCs was reported after 
RF-UVA treatment, indicating a potential cytotoxicity issue from the crosslinking process [17].  A 
comprehensive investigation of the evolution of the extracellular matrix (ECM) in the diseased 
cornea under RF-UVA crosslinking is critical to both gaining insight into disease mechanisms and 
maximizing therapeutic strategies to salvage the cornea.  Therefore, the goal is to develop new 
therapeutic agents for corneal crosslinking to re-establish normal cornea architecture and 
mechanical properties while remaining biocompatible. Considering the limited linkages between 
the collagen fibril and the PG due to shortage of functional groups, disperse ECM components or 
specific PGs would serve well as crosslinkers for the crosslinking reaction.  The crosslinking 
conditions, including the reaction medium, the dosage of the bio-crosslinkers, and the exposure 
time, would need to be evaluated and optimized. ECM changes that occur with bioinspired 
therapies could be tested in rabbit cadaver eyes. 
1.2. Complex Collagen Organization in Corneal Stroma 
The structure of corneal tissue makes it challenging to engineer and mimic. The cornea has a highly 
organized and complex extracellular matrix (ECM) structure making it uniquely transparent. 
Corneal tissue is avascular, and consists of three major layers: the outermost epithelium, the stroma, 
and the innermost endothelium. The stroma represents over 90% of the total cornea, sparsely 
populated with keratocyte cells and composed mainly of type I collagen extracellular matrix 
molecules and smaller percentages of type V collagen and proteoglycans. The corneal stroma also 
has a unique structural organization of approximately 200 lamellae, each 2-μm thick, which 
contribute to the mechanical strength and transparency of the tissue [18]. Collagen fibrils in each 
layer are aligned in parallel, but in each lamellae the alignment of the collagen fibrils is orthogonal 
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(at a right angle) to the adjacent layers above and below[19]. The orthogonally aligned collagen 
lamella with defined interfibrillar spacing gives rise to the unique property of transparency of the 
cornea tissue [20]. To date, this unique organization has not been replicated in a biomaterial on the 
size scale of the native cornea, therefore leading to inadequate functional properties. 
1.3. Current Options for Keratoplasty and Competing Strategies.  
Several strategies evolved over the years in an attempt to obviate the use of allograft corneas. As 
early as the 1980s, purely synthetic materials, such as poly(methyl methacrylate), were developed 
as corneal implants [21] and were approved for clinical use, including the Boston keratoprosthesis 
(1992) and AlphaCor (2002). Although these synthetic corneal replacements can restore vision, 
they are not able to integrate with the surrounding tissue causing graft extrusion and failure. Clinical 
reports found the failure rate of AlphaCor to be 20% in the first year and up to 58% by the third 
year [22]. Similarly, the association of the Boston keratoprosthesis with blinding glaucoma, 
endophthalmitis, and prosthesis-host intersection keratolysis has largely limited that technology to 
patients who have failed multiple conventional corneal transplantation efforts. 
More recently, researchers have moved from synthetic polymers to biological polymers to create 
corneal substitutes that are more biocompatible with the ocular surface and can potentially better 
integrate with the surrounding tissue. One such biological corneal substitute was engineered by the 
Griffith group at Linköping University (Sweden) using crosslinked collagen gels [23]. This 
biological corneal replacement was tested in preclinical pig and rabbit models [24,25] and 
translated—as a prototype derived from recombinant human type III collagen (RHCIII)—to human 
trials. Although this achievement represented an exciting shift in corneal replacements, the implant 
did not have adequate mechanical strength to support standard suturing techniques, such as single 
interrupted sutures[26]. This limited mechanical integrity is likely due to the low collagen density 
and lack of collagen fibrillar organization in the implants compared to the native tissue. Recent 
approaches taking advantage of the liquid crystal properties of highly concentrated collagen 
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solution have been developed, such as long-term dialysis[27] and molecular crowding to produce 
collagen fibrils and organized lamellae[28]. These methods are able to create thin collagen 
membranes with lamellar structures that are similar to the native cornea structure, but owing to the 
viscosity of these highly concentrated collagen solutions, it is thus far challenging to manufacture 
materials with a thickness relevant for corneal transplantation. Finally, synthetic materials such as 
functionalized silk and PLGA membranes, although effective cell carriers, may cause significant 
immune responses similar to other synthetic materials in the eye, in addition to the difficulties in 
clinical translation due to requirement of cell seeding, and the lack of thickness, strength, and 
transparency. 
 
Table 1.1 Strengths and weaknesses of emerging approaches to create biosynthetic corneas 
Material Strengths Challenges 
Crosslinked RHCIII 
biosynthetic cornea[29] 
Transparent, in vivo, in 
clinical stage 
Not suturable, lacks corneal 
ultrastructure 
RGD functionalized silk[30] Cell alignment on 
individual sheets 
Fibroblasts seeded – less 
translatable, thin, no mechanical 
data 
Collagen constructs[28] Cornea mimetic structure Non-implantable, no mechanical 
data 
TEC PLGA membranes[31] Effective cell carrier, 





CD-Col vitrigels Transparent, suturable, 
biomimetic, 
biocompatible 
Optimization and mechanism 
studies required 
 
Currently, there is no corneal substitute that mimics native cornea’s suturability, thickness, and 
transparency. A corneal substitute would benefit patients with failed corneal transplants or those 
that have an underlying condition that precludes corneal transplant.  
1.4. Controlled Self-assembly of Collagen through Artificial Chaperones 
Artificial self-assembled cornea materials represent a new paradigm in guided self-assembly 
processes. Using synthetic chaperone molecules with biologically derived materials may spur 
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innovation in understanding and modulating biological ECM scaffold organization, spacing, and 
alignment. Such insight is relevant in multiple tissue engineering fields. The new biomaterial that 
we have developed exhibits unique properties that have not yet been achieved in a corneal 
substitute. Experimentally, we are incorporating innovative analysis in the characterization of the 
implant. 
Table 1.2 Comparison of emerging biosynthetic corneal technologies with native cornea. 








Native Cornea      
Crosslinked RHCIII      
RGD functionalized 
silk 
     
Collagen constructs      
TEC PLGA membranes      
CD-Col vitrigels      
 
Engineers have tried to mimic normal embryological development to synthesize more functional 
tissues for a variety of applications. Stem cells are frequently employed to recapitulate 
development. Here, we are mimicking the unique developmental assembly of the cornea ECM 
without a cellular component by combining CD and vitrification with collagen. The CD molecules 
mimic the small proteoglycan chaperones that help to assemble and create the complex cornea 
ECM structure during the native cornea development. Furthermore, the vitrification process 
combined with these chemistries provides the collagen concentrating and fibril assembly 
mechanism. The result of this new approach mimicking embryonic cornea ECM development using 
self-assembly is a biomaterial with the unique structure of the native cornea tissue. 
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1.5. Cornea-mimetic Biomaterial Structure and Resulting Properties. 
An ideal biomaterial for corneal transplantation would, at minimum, have three fundamental 
physical characteristics – high transparency, physiological thickness and suturability. These 
parameters are interdependent, making optimization challenging. For instance, increasing thickness 
may increase suturability, but decreases transparency. Other existing corneal biomaterials-based 
strategies have focused on only one or two of these crucial characteristics. The biomimetic corneal 
implant described in this thesis is the first example of a biomaterial that is able to achieve all three: 
transparency and sutures retention at physiologically relevant thicknesses. We believe this is 
possible due to the cornea mimetic structure of our biomaterials that demonstrate collagen fibrils 
and a macro scale lamellar organization, suggesting the underlying ultrastructure of the material 
may play a larger role in the physical characteristics of the material than previously anticipated. 
1.6. Collagen Biomaterial Processing to Create Vitrigels.  
Several innovations underpin the material development process. Collagen vitrification increased 
mechanical strength Specifically, collagen membranes with fibrillar structures were developed in 
collaboration with Dr. Toshiaki Takezawa, the inventor of collagen vitrigels [32,33,34]. In 
collaboration with the Applied Physics Laboratory (APL), processing conditions were further 
optimized to reduce vitrification time and to increase mechanical strength and transparency of the 
gels [35], and exhibit biophysical properties superior to standard amorphous collagen gels. The 
fibrillar structure of the collagen vitrigel allowed cultured corneal keratocytes to maintain their in 
vivo phenotypes (defined by morphology and gene expression) more than amorphous collagen gels 
or tissue culture polystyrene, where cells typically became fibroblastic [33,36]. These vitrified 
collagen membranes also demonstrated biocompatibility in vivo in partial corneal defects in a rabbit 
model [37]. However, these membranes were thin (~50 µm), whereas the natural cornea is humans 
500 µm.  
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1.7. Chaperone Molecules to Enhance Transparency 
To create an implant with a thickness similar to the full-thickness cornea, cyclodextrin (CD) 
molecules were introduced. CD serves as an artificial proteoglycan chaperone substitute by 
interacting specifically with the amino acids on the collagen triple helices to control fibrillogenesis 
and ultimately their alignment and self-assembly into layers. CD-collagen interactions influence 
collagen ultrastructural self-assembly, similar to the role of chaperone molecules during natural 
corneal development, facilitating the formation of lamellae within the implant, as well as collagen 
alignment within each lamella. Here, we developed a CD-collagen (CD-Col) material to 
characterize and understand mechanistically how the biomimetic structure is created and to 
translate the technology in the development of a cornea implant. 
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2. Modulation of keratocyte phenotype by collagen fibril 
nanoarchitecture in membranes for corneal repair1 
2.1. Introduction 
The extracellular matrix (ECM) is a complex mixture of macromolecules that provides an 
environment for cellular development and homeostasis unique to each tissue and organ in the 
body[38,39,40]. The cornea, in particular, has a unique ECM structure that is primarily composed 
of type I collagen. The collagen molecules in the cornea are organized at many length scales from 
the aggregation of triple helices followed by fibril formation at the nanoscale. Collagen fibrils are 
then assembled into layered lamellar plates arranged in an orthogonal orientation[41]. This fibrillar 
lamellar organization in the cornea contributes to the unique clarity of the tissue[42]. 
One remarkable feature of the ECM is a continuous change of the hierarchical structures with time 
as cellular development or differentiation evolves. In the embryonic corneal stroma, the matrix 
begins as a water-rich state and then progressively transforms into a densely packed fibrillar ECM 
characteristic of adult corneas[43]. In contrast, progressive degeneration of the ECM in the corneal 
stroma leads to keratoconus. Associated with localized corneal thinning and protrusion, 
keratoconus represents a leading reason for corneal transplantation[44,45]. On the other hand, when 
the corneal stroma is injured, keratocytes, the corneal stromal primary cell type, respond readily 
but transition towards a fibroblast and myofibroblast phenotype and generate scar tissue[46,47]. 
Therefore, the ECM architecture is both a consequence and a cause for the development, 
degeneration, and regeneration of the tissue. 
                                                     
1 Text and figures in this chapter reprinted from Biomaterials 2013, 34 (37), Guo, Q.; Phillip, J. M.; Majumdar, S.; Wu, 
P. H.; Chen, J.; Calderon-Colon, X.; Schein, O.; Smith, B. J.; Trexler, M. M.; Wirtz, D.; Elisseeff, J. H., Modulation of 
keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair, 9365-72, (2013), with 
permission from Elsevier (Copyright license number: 4171410485526) 
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Maintaining the keratocyte phenotype during wound healing represents a significant challenge in 
corneal repair and regeneration[48,49]. Type I collagen is a natural choice employed frequently as 
an engineered ECM substitute for corneal repair[23]. However, conventional collagen gels are 
composed of loose networks of type I collagen fibrils with little organization, which is hardly 
comparable to the collagen structure in cornea. Compression of conventional collagen gels has been 
employed to increase collagen density and stiffness by applying a load onto the gel[50]. These 
plastically compressed collagen matrices improved cell expansion and stratification of corneal 
limbal epithelial cells, but still showed limited success in maintaining the cellular 
phenotype[51,52]. In contrast, amniotic membrane (AM), a naturally derived ECM product used 
clinically to aid in corneal re-epithelialization, was able to preserve the characteristic morphology 
and keratocan expression of keratocytes[53]. However, amniotic membrane lacks standardization 
in its sources and processing method[51]. Recently, we used vitrified collagen biomaterials 
(collagen vitrigel, CV) developed by Takezawa et al.[32] to culture various cell types found in the 
cornea with the ultimate goal of developing corneal substitutes[33,54]. CVs are synthesized from 
type I collagen, and could be standardized with straightforward manufacturing and handling 
procedures. During vitrification, collagen gels are exposed to a specific temperature and humidity 
that cause controlled evaporation of the water and organization of collagen fibrils. This vitrification 
process mimics, to some degree, the collagen maturation that occurs during the developmental 
formation of the corneal stromal ECM[43,55]. More recently, we completed a design-of-
experiments to evaluate the effects of time, temperature and humidity variables on collagen fibril 
structure, optical, mechanical, and thermal properties of CVs[35]. Ultimately, a variety of fibrillar 
structures were obtained that had a significant impact on strength and transparency. However, the 
effects of collagen nanoarchitectures created through vitrification processing on keratocyte 
responses remain unknown. 
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The purpose of this study was to evaluate the biological response of keratocytes to CVs with 
varying fibrillar content and organization. We hypothesize that CVs with controlled fibrillar 
collagen may provide an optimal environment for maintaining the keratocyte phenotype. CV 
properties were manipulated by using different temperatures and processing times during 
vitrification. Keratocyte response was characterized by cell morphology and gene expression under 
either serum-free or serum-based cultures. Typically, in previous studies, keratocyte phenotype was 
analyzed qualitatively[48]. Here, we quantitatively examined keratocyte morphology in terms of 
cell size, protrusion number, and protrusion length, using a custom-designed program written in 
MATLAB (MathWorks, Natick, MA)[56,57,58].We also evaluated the effect of the CVs’ collagen 
nanoarchitectures on various keratocyte gene expressions, including the expressions of keratocan, 
aldehyde dehydrogenase (ALDH), and biglycan.   
2.2. Materials and methods 
2.2.1. Preparation of collagen membranes 
Collagen membranes were prepared in a three-step procedure, as previously described[33]. First, 
conventional collagen gel was formed by mixing equal volumes of 0.5% type-I collagen solution 
(native collagen from bovine dermis, pH ¼ 3.0, AteloCell, Cosmo Bio Co., Ltd., Tokyo, Japan) 
and culture medium containing Dulbecco’s Modified Eagle’s Medium (DMEM), 10% fetal bovine 
serum (FBS), 20 mM hydroxyethyl piperazineethanesulfonic acid (HEPES), 100 units/mL 
penicillin, and 100 mg/mL streptomycin. The mixed solution of 2.0 mL was quickly poured into 
one well of a 6-well plate, and then incubated at 37 °C for 2 h to complete the gelation of the 
collagen. Second, the collagen gel was aseptically vitrified by drying under a controlled 
temperature and relative humidity for a prescribed time period from half week up to 8 weeks. The 
relative humidity of 40% was used unless otherwise specified. The collagen gel was first vitrified 
over 3 days and then rinsed thoroughly with PBS buffer three times for 10 min each to completely 
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remove the serum-based culture medium. The collagen gel was further vitrified until a 
predetermined time was achieved, leading to the formation of a rigid glasslike collagen membrane. 
Third, the collagen membrane was thoroughly rehydrated with PBS buffer before use. The 
thicknesses of CVs right before and after rehydration were calculated from measuring the weight 
and assuming a constant density of 1 g/mL.  
2.2.2. Transmission electron microscopy (TEM) 
The nanostructure of collagen membranes was examined by TEM. Samples were fixed in 3% 
paraformaldehyde, 1.5% glutaraldehyde, 5 mM MgCl2, 5 mM CaCl2, 2.5% sucrose, and 0.1% 
tannic acid in 0.1 M sodium cacodylate buffer at pH 7.2 overnight at 4 °C. After buffer rinse, 
samples were post-fixed on ice in the dark in 1% osmium tetroxide for 1 h. Following a DH2O 
rinse, plates were stained with 2% aqueous uranyl acetate (0.22 mm filtered, 1 h, dark) and 
dehydrated in a graded series of ethanol before being embedded in Eponate 12 resin (Ted Pella, 
Inc., Redding, CA). Plates were polymerized for two to three days at 37°C before transferring them 
to 60 °C overnight. Thin sections, 60e90 nm, were cut with a diamond knife on the Reichert-Jung 
Ultracut E ultramicrotome and then placed on naked copper grids. Grids were stained with 2% 
uranyl acetate in 50% methanol. They were imaged with a Hitachi 7600 TEM at 80 kV. Images 
were captured with an AMT CCD (1k x 1k) camera (Advanced Microscopy Techniques, Woburn, 
MA). TEM images of both transverse and coronal planes in the CV central portions were obtained. 
ImageJ (NIH, Bethesda, MD) were used to analyze the collagen fibril organization in CVs, 
including the fibril diameter, fibril density, and D-periodicity of collagen banding. Specifically, 
both fibril diameter and D-periodicity of collagen banding were evaluated fromw50 collagen fibrils 
in the transverse plane view of the TEM images. The fibril density was obtained based on the 
measurements of four different locations in the coronal plane view of the TEM images. 
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2.2.3. Keratocytes isolation and culture 
Full-thickness corneas were harvested from bovine eyes within 36 h after slaughter. Keratocytes 
were isolated using a sequential collagenase (Type 2, Worthington Biochemical Corp., Lakewood, 
NJ) digestion. Specifically, bovine corneas were collected and cut into small pieces with a scalpel 
and then transferred to a 50-mL centrifuge tube containing 3 mg/mL collagenase in DMEM/F-12. 
The corneal pieces were incubated on a rotary shaker at 240 rpm at 37°C for 60 min and then 
collected using a 70 mm cell strainer (BD Falcon, BD Biosciences, San Jose, CA). The partially 
digested corneas were transferred to a fresh collagenase solution for a second digestion for 60 min. 
This process was repeated for a third digestion for 120 min, and the digested cells from the third 
digestion were collected and centrifuged at 1400 rpm for 10 min. The cell pellet was resuspended 
and cultured on general tissue culture plates (TCP) or CV-covered plates at 37°C and 5% CO2. 
Either serum-free or serum-based culture medium was used. The serum-free medium consisted of 
DMEM/F-12, 1% of 10 U/mL penicillin-streptomycin, and 0.5% of 1.25 mg/mL amphotericin B 
(Life Technologies, Carlsbad, CA). The serum-based medium contained DMEM/F-12, 10% FBS, 
1% of 10 U/mL penicillin-streptomycin, and 0.5% of 1.25 mg/mL amphotericin B. The cells were 
plated at a concentration of 5000 cells/cm2 using the serum-free medium, while at a concentration 
of 1000 cells/cm2 using the serum-based medium. Before imaging and gene expression analyses, 
keratocytes were cultured over 3 weeks in serum-free medium or 6 days in serum-based medium. 
Keratocyte morphologies were examined by staining with the LIVE/DEAD Viability/Cytotoxicity 
Kit (Life Technologies). 
2.2.4. AlamarBlue assay 
Proliferation of keratocytes was measured by AlamarBlue assay (Invitrogen, Frederick, MD). This 
assay employs a fluorometric/colorimetric growth indicator that changes from an oxidized (non-
fluorescent, blue) form to a reduced (fluorescent, red) form when reduced by mitochondrial 
15 
 
respiration of the cells. In this assay, the percent reduction of AlamarBlue, which is determined by 
the ratio of the concentration of the reduced form to the total concentration of AlamarBlue, is 
proportional to the number of cells. Primary keratocytes were plated in 24-well plates at a 
concentration of 5000 cells/cm2 using the serum-free medium, or 1000 cells/cm2 using the serum-
based medium. At predetermined time points, the medium was refreshed and cells were incubated 
with 10% AlamarBlue at 37°C and 5% CO2 for 4 h. A sample of 200 mL of AlamarBlue solution 
was then transferred into a 96-well plate for fluorescence reading. The absorbance was monitored 
at 570 nm and 600 nm using a fluorescence plate reader (Synergy 2, Biotek, Seattle, WA). The 
proliferation of keratocytes was determined by the increase of AlamarBlue reduction at Day 4 
relative to Day 2. This assay was performed in four independent experiments. 
2.2.5. Quantification of cellular morphology 
Image processing for quantification of the cellular morphological features from fluorescent images 
was carried out using a custom-designed program developed in MATLAB[57,58]. In brief, we first 
segmented individual cells in images and measured the cell spreading area. For the quantification 
of protrusion morphology, we first determined the morphological skeleton of individual cell 
contours and identified the main body region of cells[59]. The protrusions were identified as the 
skeleton structures that were extended beyond the main body region. The protrusions were further 
classified into two subtypes: 1st order protrusions and 2nd order protrusions. The 1st order 
protrusions were considered to be the protrusions stemming directly from the cell body, and 2nd 
order protrusions were the ones branching from other protrusions. The length of each protrusion 
was measured and the total number of protrusions for individual cells was determined as the 
summation of 1st order and 2nd order protrusions. The morphology of keratocytes, including cell 
size, total number of protrusions, mean length of protrusions, primary protrusion number, 
secondary protrusion number, and the ratio of secondary to primary protrusions, was evaluated 
based on the measurements of w60 cells. 
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2.2.6. Gene expression analysis 
Total RNA was isolated from cultured keratocytes using TRIzol reagent (Life Technologies) and 
reverse transcribed into cDNA using SuperScript II First Strand Synthesis Kit (Life Technologies). 
cDNA was used for real-time PCR reactions using a StepOnePlus Real-Time PCR System (Applied 
Biosystems, Life Technologies). The PCR primer sequences are listed in Table 1. GAPDH was 
used as a reference gene. The relative gene expression was determined using the 2eDDC(T) 
method[60]. 
2.2.7. Statistics 
Data were represented as averages +/- standard deviations, unless otherwise specified. Two-tailed 
unpaired t-tests were performed to determine significance using GraphPad Prism (GraphPad 
Software Version 5, GraphPad Software, Inc., La Jolla, CA). p value of <0.05 was considered 
statistically significant. 
2.3. Results 
2.3.1. Collagen vitrigel preparation and nanoarchitecture  
CVs were prepared following a three-stage sequence: gelation, vitrification, and rehydration 
(Figure 2.1A)[33,35]. When the collagen solution containing 2.5 mg/mL type I collagen was first 
gelled at 37°C for 2 h, it produced a collagen gel with a thickness of 2.0 mm. This collagen gel was 
translucent and soft. During vitrification, the collagen gel was dried slowly at a controlled 
temperature of either 5°C or 39°C under a relative humidity of 40%. This resulted in CV formation 
with a dramatically decreased thickness. After vitrification at 5°C for 2 wk, the vitrified gel had a 
thickness of 9 _ 1 mm, which is a 220-fold decrease in the thickness of the membrane. To compare, 
the CV vitrified at 39°C for 2 wk exhibited a smaller thickness of 6 _1 mm, which is a 330-fold 
17 
 
decrease in the thickness. After rehydration, the CV still maintained its shape and swelled in PBS 
buffer to form a hydrated membrane with a thickness of approximately 50 mm. 
CVs reconstructed from highly hydrated collagen gels showed a distinctive nanoarchitecture. Fiber 
morphology depended on the CV conditions as visualized through TEM images in the middle 
portions. A three-dimensional view of a CV (5°C, 2 wk) is shown in Figure 2.1B. Unlike 
conventional collagen gel showing homogeneous distribution of the collagen fibrils, this CV 
demonstrated a random fibrillar organization in the transverse plane, but showed a layer-by-layer 
lamellar structure in the coronal and sagittal planes. Similar results were also observed in all the 
other CVs, even for the CV 5°C, 0.5 wk that was vitrified for a short time period (Figure 2.2A-H). 
The organization of the collagen fibrils was strongly affected by the vitrification processing 
conditions, including the temperature and the vitrification time. First, no significant difference in 
collagen fibrillar diameter was observed in despite of varying vitrification temperature and 
vitrification time (Figure 2.2I). Second, all of the samples clearly showed the characteristic 
collagen banding with spacing around 60 nm (Figure 2.2J). No significant difference in D-
periodicity was observed at different temperatures and vitrification times. Third, at a constant 
temperature, the collagen fibril density dramatically increased along with the vitrification time 
(Figure 2.2K). The fibril density of the CV at 5°C for 0.5 wk is as low as 5 fibers/ mm2. After 
vitrification at 5°C for 2 wk, the fibril density was dramatically increased to 95 fibers/mm2. For 
the CVs prepared at 39°C, the fibril density was very high and close to the maximum density of the 
fiber in the collagen matrix, which was estimated to be 180 fibers/mm2 based on an assumption of 
hexagonally arranged collagen fibrils with fibril diameter of 80 nm. Therefore, the collagen fibril 
density increased with vitrification temperature, which is consistent with the decreased membrane 
thickness as we observed above. Furthermore, collagen fibrils with large bending curvature 
decreased in the CVs prepared at a higher temperature and/or longer vitrification time when 
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comparing the CVs vitrified for 2 wk at 5°C vs. 39°C, vitrified at 5°C for 0.5 wk vs. 2 wk, and 
vitrified at 39°C for 1 wk vs. 2 wk (Figure 2.2A-D).  
2.3.2. Morphology and proliferation of sub cultured keratocytes 
The CV nanoarchitecture modulated keratocyte morphological response. Typical morphologies of 
keratocytes cultured on these CVs are shown in Figure 2.3A-H. Characteristic stellar phenotype of 
cultured keratocytes was observed using serum-free medium (Figure 2.3A-D). Compared to the 
TCP control, the keratocytes cultured on CVs had more and longer protrusions, as well as more 
intercellular connections. The number and length of keratocyte protrusions increased on the CVs 
processed for longer vitrification times. Moreover, more pinning points were observed in the 
extended protrusions of the keratocytes cultured on the CV processed for a longer time, especially 
on the CV 39°C, 8 wk (Figure 2.3A-D). Keratocyte morphology under serum-free culture was 
analyzed quantitatively with a custom-designed program written in MATLAB [24,25]. Figure 
2.4A-C illustrates an example of a keratocyte cultured on CV 39°C, 8 wk. Individual cellular 
contours were first obtained identification of the cell body and protrusions (Figure 2.4B). The cell 
size was determined as the area within the cellular contour, including cell body and protrusions. 
Based on the cellular contour, the morphological skeleton was determined and the protrusions were 
classified into two subtypes depending on their starting position. Primary protrusions, or 1st order 
protrusions, were defined as the longest protrusions stemming directly from the cell body, while 
secondary protrusions, or 2nd order protrusions, were those branching from the primary 
protrusions. Keratocyte morphologies were carefully quantified, including cell size, total number 
of protrusions, mean length of protrusions, number of primary protrusions, number of secondary 
protrusions, and the ratio of secondary to primary protrusions. The cell sizes of keratocytes cultured 
on CVs were significantly higher than those cultured on TCP (Figure 2.4D), which is related to the 
increased number and length of protrusions (Figure 2.4E-F). Figure 2.4E shows that the number 
of protrusions per each keratocyte increased with the vitrification time of the CVs. Keratocytes 
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cultured on CV 39°C, 8 wk exhibited on average 27 protrusions per cell, a 70% increase over the 
average number of protrusions of those cells cultured on TCP. A similar, but smaller trend was also 
observed in the mean length of keratocyte protrusions. Interestingly, no significant difference was 
observed in the primary, or 1st order, protrusion number of the keratocytes cultured on TCP and 
CVs (Figure 2.4G). In contrast, the average number of secondary, or 2nd order, protrusions of the 
keratocytes increased markedly from 7 protrusions in TCP, to 12 protrusions in CV (39°C, 1 wk), 
to 14 protrusions in CV (39°C, 2 wk), and to 18 protrusions in CV (39°C, 8 wk) (Figure 2.4H). A 
similar trend to the secondary protrusion number was also observed in the ratio of secondary to 
primary protrusions, further demonstrating that extent of branching/number of secondary 
protrusions per primary protrusion increased as a function of vitrification time (Figure 2.4I). 
The cellular proliferation rate, determined by AlamarBlue, changed depending on the CV 
structure/morphology (Figure 2.5). Under serum-free culture and compared to the TCP control, a 
significant increase in the keratocyte population was indicated on the three CVs with highly 
condensed collagen fibrils, including CV (5°C, 2 wk), CV (39°C, 1 wk), and CV (39°C, 2 wk). 
Moreover, when comparing CV (5°C, 1 wk) vs CV (5°C, 2 wk), and CV (39°C, 1 wk) vs. CV 
(39°C, 2 wk), it is evident that the cells tended to proliferate more on the CVs that had a longer 
vitrification time. Under serum based culture, the keratocytes exhibit a fibroblastic phenotype 
(Figure 2.3E-H). No significant differences in the cellular morphology or proliferation were 
observed in any of CVs. Nevertheless, these keratocyte fibroblasts maintained their phenotypic 
markers to varying degrees based on the collagen nanoarchitectures of CVs. 
2.3.3. Keratocyte gene expression dependence on collagen nanoarchitecture 
Keratocyte gene expression, including keratocan, ALDH, and biglycan, was tested using CVs with 
different nanoarchitectures. Under serum-based culture, keratocytes lost characteristics of their 
native phenotype in TCP. Compared to TCP, the gene expression of biglycan was reduced 
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significantly using all four types of CVs (Figure 2.6). For CVs prepared at 5°C, the expression of 
keratocan was slightly lower using the CV processed for half week than in TCP, but markedly 
increased when using the CV processed for a longer period of two weeks. The expression of ALDH 
in cells cultured on both CVs vitrified at 5°C were dramatically increased compared to those 
cultured on TCP. For CVs prepared at 39°C, the expression of ALDH was slightly lower when 
employing CV vitrified for one week than that on TCP, but markedly increased when using CV 
vitrified for a longer period of two weeks. The expressions of keratocan in cells using both CVs 
prepared at 39°C were greatly raised compared to those using TCP. 
2.4. Discussion 
Vitrification provides a convenient means to manipulate the nanoarchitecture of collagen 
membranes. Lamellar structures were formed in these vitrified collagen membranes. During 
vitrification, collagen fibril density was dramatically increased, which led to a decrease of fibril-
to-fibril distance and contributed to the enhanced transparency and mechanical properties reported 
previously[35]. In addition, fewer collagen fibrils with large bending curvature were observed in 
the CVs prepared under longer vitrification times, indicating that the collagen fibrils became stiffer 
during vitrification. This may be explained by new and/or more stable interactions formed in the 
collagen fibrils through the vitrification process, which is consistent with our previous results 
showing increased thermal stability of CVs with vitrification time[35,61]. No significant difference 
was observed in the collagen fibril dimension and periodic banding distance. The maintenance of 
collagen banding periodicity suggests that the CVs were not denatured during the vitrification 
process, even under the high temperature of 39°C that is above the normal human body temperature 
range. This is because the denaturing temperatures of these CVs we observed previously were 
between 54 and 59°C, much higher than the CV processing temperature[35]. The processing of 
collagen membranes by vitrification likely resembled, to some extent, the collagen maturation in 
embryonic corneal stromal development because condensed collagen lamellae composed of 
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collagen fibrils were formed with new and stable interactions[43]. The flexibility in collagen 
ultrastructure of CVs provided a vehicle to investigate the effect of nanofibrillar matrix on cellular 
responses. In this study, the organized collagen membranes supported the growth of keratocytes in 
serum-free medium when cells generally do not proliferate. On the other hand, cells proliferating 
under serum-based culture on the CVs were able to maintain a keratocyte phenotype instead of 
dedifferentiating into fibroblasts. CVs prepared using longer vitrification times were preferable, as 
they offered an extracellular environment that more closely mimicked the natural corneal stroma. 
Human corneal stroma has been reported to consist of collagen fibrils with a diameter of 36 nm at 
a high density of about 700 fibers/mm2[62]. In our study, the highest collagen fibril density in the 
four CVs studied almost reached a maximum of 180 fibers/mm2, assuming no fibril-fibril spacing. 
Our fibril diameter, at about 80 nm or above (Fig. 2), was more than twice that in naturally 
occurring corneal stroma. Thus, creating a further increase in collagen fibril density will require 
significantly reducing the collagen fibril diameter. Collagen fibril condensation could also be 
achieved by plastic compression of conventional collagen gels, but to an even lesser degree as 
compared to vitrification[50]. 
Quantitative analysis of the effect of collagen nanoarchitecture on keratocyte phenotype is a 
potentially powerful method to correlate cell morphology and gene expression/phenotype. No 
systematic studies have been reported in which the effect of different extracellular environments 
on the keratocyte phenotype was quantified. This is important when designing and testing new 
biomaterials for corneal reconstruction. We found that the secondary protrusions of keratocytes 
played a critical role in defining the phenotype. In contrast, their primary protrusion numbers 
remained constant at different CV processing conditions. Both total protrusion number and length 
increased significantly with increased vitrification time. This suggests that the collagen membranes 
consisting of highly condensed collagen fibrils provided a proper environment for the formation of 
characteristic dendritic morphology of keratocytes. Keratocytes also maintained their phenotype 
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characteristics in CVs under serum-based culture. Typically, primary keratocytes express a low 
level of biglycan, but high levels of keratocan and ALDH. In particular, keratocan is one of the four 
proteoglycans found in the adult corneal stromal ECM that plays an important role in maintaining 
fibrillar ECM nanostructures and stromal transparency[43]. ALDH is the main water-soluble 
protein in mammalian corneas and provides protection against ultraviolet radiation and reactive 
oxygen-induced damages in ocular tissues[63]. In contrast, biglycan is a sensitive marker that is 
associated with the fibroblastic transition of the keratocytes during pathological remodeling of the 
corneal stroma[46]. Both down-regulation of biglycan and upregulation of keratocan and ALDH 
were observed using CVs, especially in those with longer vitrification times. The CVs prepared at 
5°C promoted gene expression of ALDH higher than of keratocan, whereas the CVs prepared at 
39°C favored the up-regulation of keratocan more than of ALDH. This may result from different 
types of interactions that were formed between the collagen molecules during the vitrification 
process at different temperatures, which is a unique phenomenon observed in collagen processing. 
Many techniques have been reported to manipulate collagen organizations. For instance, collagen 
matrix stiffness has been modified by changing collagen concentration[64], tuning crosslinking 
density[65,66], or employing a compressive load[52]. Collagen fibril alignment has been controlled 
by applying a shear force[49,67]. 
Nevertheless, none of these techniques mimic the process of collagen maturation as observed in 
vitrification of collagen membranes showing continuous formation of new interactions between 
collagen molecules inside collagen fibrils. The utility of vitrification processing to tailor the 
nanoarchitecture of ECM or biomimetic biomaterials may be useful for various clinical 
applications. For instance, keratoconus is a disease where the corneal stromal matrix becomes 
disrupted and loses this fine structural organization. The application of local vitrification in the 
diseased cornea might offer a route to reorganizing the stromal matrix and eliminating corneal 
protrusion. In addition, the CV with a biomimetic collagen nanoarchitecture holds great potential 
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as a corneal substitute that supports the growth of keratocytes and preserves the cellular phenotype. 
Similar biomaterials can also be designed to use as potential substitutes for other connective tissues 
such as cartilage, skin, and muscle. 
2.5. Conclusion 
This study fabricated CVs with unique engineered biomaterial scaffolds that provided an ex vivo 
template mimicking the native environment of corneal stroma. The well-organized collagen 
matrices developed in CVs were obtained through a highly controlled vitrification processing 
method. This collagen vitrification process resembled, to some extent, the normal collagen 
maturation in corneal stroma. This processing technique also provided collagen scaffolds with 
variable nanoarchitectures that may offer a method to study collagen degeneration and thereby be 
helpful in elucidating the etiology of the diseases related to a changing ECM. As illustrated in this 
study, the highly condensed collagen matrices in CVs allowed the proliferation of keratocytes, even 
without serum; and with serum, they helped to maintain the characteristic phenotypes of the cells. 
We suggest that with further development, CVs may be used to create a corneal substitute and guide 
corneal repair by placing an acellular scaffold into a defect, and allowing migration of the patient’s 










Figure 2.1 Collagen vitrigel preparation and alignment: (A) three-step procedures, and (B) TEM image 





Figure 2.2 TEM images of CVs and collagen fibril analysis: (A-D) Transverse plane, (E-H) coronal plane, 
and (I-K) collagen fibril analyses. Four CVs were used: (A, E) CV 5°C, 0.5 wk, (B, F) CV 5°C, 2 wk, (C, G) 
CV 39°C, 1 wk, and (D, H) CV 39°C, 2 wk. Collagen fibril analyses include (I) fibril diameter, (J) d-
periodicity (banding), (K) fibril density. The TEM samples were obtained from the center portions of the 
collagen membranes. Collagen fibrils with large bending curvature were indicated by triangle. The error bars 






Figure 2.3 Keratocyte morphologies cultured on CVs using two different culture media: (A-D) serum-
free culture medium, and (E-H) culture medium with 10% FBS. Four cell culture substrate conditions were 
used: (A, E) TCP control (B, F) CV 39°C, 1 wk, (C, G) CV 39°C, 2 wk, and (D, H) CV 39°C, 8 wk. Pinning 





Figure 2.4 Morphological analysis of keratocytes cultured on CV vitrified at 39°C using serum-free 
medium. (A-C) A keratocyte example cultured on CV (39°C, 8 wk) (A) with cellular contour identified in 
(B) and morphological skeleton acquired in (C). Based on cellular contour and skeleton, the dependence of 
keratocyte morphologies on CV vitrification processing time was examined (D-I), including cell size (D), 
total number of protrusions (E), mean length of protrusions (F), primary protrusion number (G), secondary 
protrusion number (H), and the ratio of secondary to primary protrusions (I). The error bars in (D-I) represent 
the standard deviation of the mean. Keratocytes cultured on the TCP were tested as a control. All statistical 





Figure 2.5 Effects of CV processing conditions on the proliferation of primary keratocytes cultured in 
serum-free medium. The CVs were processed from 0.5 wk up to 2 wk at two different temperatures (5°C 
and 39°C). The proliferation of keratocytes at Day 4 relative to Day 2 was assessed using an AlamarBlue 





Figure 2.6 Gene expression of keratocytes fibroblasts seeded on CVs processed under different 
conditions and cultured in serum-based medium. All statistical differences are indicated with the ones 
against TCP control showing above each bar, and the others comparing CV groups portrayed on lines. *p < 







3. Tissue Derived Extracellular Matrix stabilizes ectatic corneal 
biomechanics and ultrastructure2 
3.1. Introduction 
The cornea is the outermost layer of the eye, which functions as a protective and light-refractive 
tissue. Corneal stroma represents about 90% of the corneal in thickness, composed of a collagen-
rich extracellular matrix (ECM) with highly aligned collagen fibrils formed densely packed 
lamellae [68]. This unique ultrastructure provides excellent transparency and mechanical stability 
to the cornea. Diseases or injuries of the cornea that cause changes in the ultrastructure negatively 
impact corneal mechanical and optical properties. Corneal ectasia, and more specifically 
keratoconus, is an ocular disorder caused by abnormal collagen degeneration that leads to 
weakening of the corneas, irregular astigmatism and vision loss [69]. The ultrastructural damage 
and disrupted collagen alignment in keratoconic eyes has been previously established [70,71]. The 
FDA approved clinical treatment to slow or halt the progression of keratoconus or post-LASIK 
ectasia is photochemical collagen crosslinking initiated by riboflavin (RF) under ultraviolet-A 
(UVA) irradiation [72]. While this high efficacy procedure significantly improves the mechanical 
characteristics of the corneas after treatment [73], exposure to UVA holds some risks. Prolonged 
UVA irradiation can cause extensive keratocyte loss or even corneal endothelial cell damage 
[74,75]. This method is therefore not suitable for patients with thin corneas (<280 µm). 
As part of the natural aging process, corneal crosslinking occurs via the Advanced Maillard 
Reaction [76], which involves proteoglycan components in the cornea. Further, during prenatal 
corneal development and corneal wound healing, other ECM components such as proteoglycans 
                                                     
2Text and figures from this chapter adapted from a currently unpublished manuscript with permissions from authors. H. 
Yin*, X. Wang*, S. Majumdar, J. Sohn, W. Stark, J.H. Elisseeff, Tissue Derived Extracellular Matrix stabilizes ectatic 
corneal biomechanics and ultrastructure. 
32 
 
play an important role to regulate corneal fibril size and spacing, which has a critical impact on 
corneal optical and mechanical properties [77,78]. It has been reported that ECM proteins such as 
the decorin core protein, can reinforce porcine corneas ex vivo [79]. ECM is a collection of 
biological molecules secreted by the cells carrying structural and biological cues to regulate cellular 
activities. In regenerative medicine, ECM is typically used in the context of scaffolds for tissue 
engineering [80,81], and porcine bladder-derived ECMs are already available clinically as wound 
care products [82]. However, the functions of ECM surpass mere structural support, providing key 
biological cues to regulate cell behavior such as proliferation, migration and differentiation [83,84]. 
We have also recently demonstrated that ECMs exhibit an immune-regulatory role through the T-
cell pathway in a mouse volumetric muscle loss model [85]. Tissue derived ECM materials such 
as amniotic membranes also have been applied in ophthalmological research, used for wound 
healing or as cell carriers for limbal stem cell deficiencies [86,87]. However, very few studies have 
focused on the impact of ECM on corneal biomechanics. To bridge this gap in literature, in our 
present study we evaluate the effect of tissue-derived ECMs on the reinforcement of corneal 
biomechanics and extent of restoration of native collagen ultrastructure in damaged corneas. We 
produced ECM microparticles from multiple organ sources, and studied their effect on an 
established enzyme-mediated ex vivo keratoconus model [88].   
3.2. Materials and Methods 
3.2.1. ECM conditioned medium preparation 
Porcine eye globes, knee joints and lymph nodes were purchased from local slaughter house. 
Corneas (COR) from the eyes, cartilage (CART) from the knee joints, and lymph node (LN) tissue 
were dissected from adjoining tissue. The tissues were thoroughly washed with tap water and frozen 
before decellularization. Using a standard decellularization process, the tissues were thawed and 
ground with knife mill, followed by treatment with 3% peracetic acid (Sigma Aldrich) on a stir 
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plate for 4 hours (500 ml 3% peracetic acid per 20 g of minced tissue). After acid treatment, the 
minced tissue was washed extensively with tap water followed by deionized (DI) water until the 
pH was neutralized. The samples were then treated with 5% Triton-X for 48 hours, followed by a 
final digestion with DNase (Roche) overnight. The decellularized minced tissue was lyophilized 
and then cryomilled into microparticles before use. To prepare ECM conditioned media, the ECM 
microparticles were suspended in full media (DMEM+10% FBS+1% antibiotic-antimycotic) at 
concentration of 1 mg/ml overnight, and then filtered through a 0.22 μm filter before use.  
3.2.2. Ectatic corneal (KC) culture in ECM conditioned media 
Fresh albino rabbit eyes (Cat. #41211-2) were purchased from PelFreez Biologicals (Rogers, AR). 
To create the ex vivo keratoconus model (KC) corneas, the eyes were treated with 0.1 U/ml 
chondroitinase ABC (C36675U Sigma Aldrich) by immersing the anterior surface in enzyme 
solution for 2 hours. Following enzyme treatment, the eye globes were washed with full media 
several times. The corneas were then treated to the different ECMs, by submersing the anterior 
segment in ECM containing 4% dextran for 18 hours. 
3.2.3. Optical coherent tomography (OCT) 
The ex vivo eye globes were imaged with Envisu R4110 SDOCT system (Bioptigen) with light 
source with an output power of 10 mW, and an effective bandwidth of 105 nm centered at 845 nm, 
which provides an axial resolution of 3.0 μm in air for the experiment. The transversal resolution 
is approximately 12 μm, assuming a Gaussian beam profile. The scanning area of each cornea had 
a width of 4.8 mm and depth of 1.2 mm. 
3.2.4. Transmission electron microscopy  
Samples before and after ECM treatment were stored in 20% Dextran-500 overnight to minimize 
any swelling effects before fixation. The fixative contained 3% paraformaldehyde, 1.5% 
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glutaraldehyde, 5 mM MgCl2, 5 mM CaCl2, 2.5% sucrose, 0.1% tannic acid in 0.1 M sodium 
cacodylate buffer, at pH 7.2. Samples were fixed overnight at 4oC, then post-fixed in 1% osmium 
tetroxide, followed by staining with 2% aqueous uranyl acetate and dehydrated in increasing 
concentrations of ethanol (from 30% to 100%). Thin sections (60-90 nm) were cut and stained with 
lead and uranyl acetate. Sections were observed with Philips/FEI BioTwin CM120 Transmission 
Electron Microscope at 80kV.  
3.2.5. Image analysis:  
TEM images were analyzed using MATLAB program, using code that was previously established 
[88]. Original images were binarized using an adaptive thresholding method. To estimate the 
density of fibers, a window of fixed size (300x300 dpi) was randomly localized. Within the 
window, the density (i.e. the number of fibers per unit area) was measured and recorded. This 
random procedure was repeated 200 times and the density of fibers was estimated using the median 
number. 
3.2.6. Tensile test 
Uniaxial tensile testing was carried out to determine the stress-strain behavior of the corneas before 
and after ECM treatment. All samples for tensile testing were stored in 20% dextran-500 solution 
overnight to minimize swelling. Corneas were cut into 5 mm stripes, and the thickness of the stripes 
was recorded. Superglue was used to fix both ends of the corneas to sample clamps to avoid 
slippage. The tensile test was performed at the rate of 0.01 mm/s on Bose EnduraTEC ELF3200 
using a 2 N load cell. Load and displacement were recorded by software WinTest. 
3.2.7. Differential scanning calorimetry (DSC) 
The thermal stability of the corneas was assessed using the DSC 8000 (Perkin Elmer, Waltham 
MA). Three corneal samples from each treatment group were obtained using a 6-mm biopsy punch 
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and placed in 30 μL aluminum pans and crimp-sealed. An empty pan was used as reference in all 
samples. DSC was performed over a temperature range of 10oC to 95oC, at a rate of 5°C per minute 
under a 20 mL/min nitrogen flow. Denaturation temperatures were detected and analyzed with the 
Pyris software (Perkin Elmer) version 10.1. 
3.2.8. Gene expression  
Corneas were flash-frozen in liquid nitrogen and broken into small segments using ceramic pestles. 
The corneal segments were treated with TRIzol (ThermoFisher) and the total RNA was collected 
with RNeasy Mini Kit (Qiagen). The mRNA concentrations were quantified by Nanodrop-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE), and then reverse-transcribed with 
High Capacity cDNA kit (Applied Biosystems). QPCR was performed with SYBR Green qPCR 
Mastermix (Applied Biosystems), and expression levels were normalized using housekeeping gene 
Gapdh. The primers of the targeted genes are listed in Table 3.1. 



















3.2.9. Statistical Analysis 
Student’s t-test was used to statistically examine differences between control, KC and ECM treated 
corneas in terms of collagen fibril diameter and density. Young’s modulus, and gene expression 
were analyzed with Prism 6.01 (GraphPad Software, Inc., San Diego, CA) using one-way analysis 
of various (ANOVA). All experiments were repeated twice independently, with n=6 for each 
experimental group. P-values <0.05 were considered statistically significant. 
3.3. Results 
To determine the potential use of ECM treatment as an alternative to photo-crosslinking, we first 
enzymatically induced corneal weakening and degradation to simulate corneal ectasia and then 
treated the KC eyes to various ECM conditioned media to demonstrate restorative effects of ECM 
(Figure 3.1). We characterized changes in the corneas in terms of mechanical characteristics, 
thermal properties, ultrastructural organization and gene expression both pre- and post-treatment.  
3.3.1. Corneal structural changes after ECM treatment  
As a convenient and non-invasive technique to visualize corneal cross sections, OCT was used to 
measure changes in thickness and light scattering after enzyme digestion and ECM treatment 
(Figure 3.2). Unwounded control corneas cultured in full medium (without ECM) for 18 hours, 
were measured at a thickness of around 500-600 µm. The typical rabbit corneal thickness is 350-
370 µm, therefore despite presence of 4% dextran-500 in the culture medium, a certain extent of 
corneal swelling ex vivo is expected. Corneas after enzyme digestion (KC), despite the lower 
collagen/proteoglycan content, demonstrated thicknesses comparable to control cornea and hyper-
reflection of light in the OCT images, indicating extensive swelling and reduced transparency after 
KC treatment. KC corneas which were treated with ECM however did not show the same swelling 
behavior and presented lower thickness values. ECM treated corneas also did not demonstrate the 
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hyper-reflection seen in KC corneas. Particularly, light reflection in the OCT images of the COR 
corneas was markedly similar to unwounded control corneas.  
TEM was used to identify changes in collagen fibril density of the KC corneas before and after 
ECM treatment (Figure 3.3). Chondroitinase enzyme activity on the KC corneas degraded 
proteoglycan chains in the cornea, resulting in a lower fibril density compared to unwounded 
controls. The loss of proteoglycan content also contributed to a larger average fibril diameter, due 
to swelling during fixation. KC corneas had a larger average fibril diameter, lower fibril density 
and a similar pattern of fibril distribution compared to unwounded control corneas. Treatment of 
the KC corneas with ECM significantly increased fibril density, restoring the normal collagen 
architecture to varying extents. Collagen fibril diameter and density differed with different ECM 
treatments (COR, CART, LN). In comparison to unwounded controls, the COR group presented 
smaller median fibril diameter size but a larger fibril diameter distribution, CART group 
demonstrated similar fibril diameter, and LN group exhibited the smallest fibril diameters. 
Additionally, the LN group also exhibited the highest collagen fibril density.  
3.3.2. Corneal mechanical properties and thermal stability after ECM treatment  
Mechanical properties and thermal stability of the KC corneas were evaluated following ECM 
treatment. Uniaxial tensile testing demonstrated significant reduction in the elastic modulus of KC 
corneas after enzyme treatment. Following ECM treatment, elastic modulus of the KC corneas is 
restored and there was no statistical significance between the moduli of different ECM treatments 
and the unwounded controls (Figure 3.4A). Representative stress-strain curves also demonstrate 
the effect of the reinforcement through ECM treatment at higher strain values (Figure 3.4B). 
Thermograms obtained using the DSC clearly display variations in the denaturation temperatures 
of control and KC corneas via broad peaks over the 60-70°C range (Figure 3.4C). While KC 
corneas had significantly lower mean denaturation temperatures (mean value+/-°C) as compared 
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to the control corneas (mean value+/-°C), the ECM treatment restored thermal denaturation 
temperatures in all three groups (Figure 3.4D).  
3.3.3. Gene expression 
To evaluate the impact of various treatments on corneal stromal cells, qRT-PCR was performed on 
the corneas following culture in ECM conditioned media (Figure 3.5). The enzyme digestion 
significantly upregulated the pro-inflammatory marker Tnfa in KC corneas. In contrast, after KC 
corneas were treated with ECM conditioned media, Tnfα expressions were significantly down-
regulated to levels lower than control group. Keratocyte markers keratocan, Aldh and biglycan 
were also evaluated. KC groups demonstrated significant down-regulated expression of all 
keratocyte markers evaluated. Following treatment of KC corneas with ECM conditioned media, 
key keratocyte marker expressions were restored. 
3.4. Discussion 
    ECM proteins are known to play a significant role in the maintenance and preservation of tissue 
ultrastructure and biological function. This study investigates the potential application of 
leveraging these roles of ECM for structural reinforcement of the cornea to tackle the clinically 
relevant challenges of corneal ectasia. We evaluated the benefits of ECM via biomechanical, 
thermal, ultrastructural and gene expression characterization, by treating enzyme digested corneas 
with ECM conditioned media. ECM treatment demonstrated an increase in Young’s modulus on 
the KC corneas. Moreover, it restored thermal stability, and regulated gene expression of corneal 
stromal cells. We have therefore conclusively established that tissue-derived ECM can significantly 
and beneficially impact corneal mechanics, stability and cell behavior.  
     Rabbit corneas are prone to swelling immediately post-enucleation, despite intact epithelial and 
endothelial cell layers. The swelling is exacerbated if any damage to the collagen structure occurs. 
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The enzyme chondroitinase ABC specifically targets chondroitin sulfate, which is a 
glycosaminoglycan in the cornea, thereby weakening the collagen-proteoglycan ECM network in 
the corneal stroma. Therefore, after enzyme digestion, KC corneas contain a lower 
collagen/proteoglycan content. Despite the collagen/proteoglycan loss, the average thickness of 
modeled KC corneas was comparable to unwounded control corneas. Additionally, hyper-
reflection of light in the OCT images was observed in KC corneas. Both these findings indicate 
extensive swelling occurred after enzyme digestion, disrupting the collagen/proteoglycan 
organization of the stroma. ECM treatment of KC corneas demonstrated a decrease in overall 
thickness and in the hyper-reflection compared to KC corneas, indicating stabilization of the 
corneal stromal architecture. TEM images also demonstrated that ECM treatment of KC corneas 
restored damaged ultrastructure and significantly condensed the collagen fibril spacing. The 
increase in collagen density corresponded with the reduction in thickness observed from the OCT 
images. In the native cornea, the proteoglycans containing chondroitin sulfate chains plays an 
important role on regulating collagen size and inter-fibrillar spacing [43]. In this ex vivo model, KC 
corneas have larger inter-fibrillar spacing and fibril diameter, which could be attributed to the 
degradation of chondroitin sulfate chains via enzymatic action, thus weakening inter- and intra-
fibrillar collagen binding. The loss of inter-fibrillar collagen binding results in lower collagen 
fibrillar density. Meanwhile, the weakened intra-fibrillar collagen binding causes loosening of the 
tight packing in individual collagen fibrils, thereby changing the collagen fibril diameter 
distribution. ECM treatment restored the fibril density and altered the fibril diameter distribution. 
Treatment with different ECM groups (COR, CART, LN) resulted in different fibril sizes and 
density distributions. The differences observed after treatment could potentially be attributed to the 
varying biological components in the tissues from which the ECMs were extracted. While 
dissimilar in the ultrastructures produced, all ECM treatment groups restored mechanical properties 
of the cornea equally. 
40 
 
    Tensile strength is an important parameter for evaluating crosslinking efficiency, to ensure that 
the corneal stroma can resist deformation due to intraocular pressure. The enzyme activity 
decreased the tensile strength of KC corneas due to the degradation of proteoglycans, similar to the 
loss of mechanical integrity in keratoconic corneas. ECM treatment of the KC corneas increased 
the Young’s moduli in all ECM treated groups by 50% compared to the untreated KC group, 
statistically comparable to the modulus of unwounded controls.  
Thermal denaturation temperature of the corneal stroma is another critical characteristic to assess 
stability of the corneas. Typical type I collagen based tissues have thermal denaturation 
temperatures ranging from 50-90°C[89], depending on various factors such as other extracellular 
matrix components and water content . We have previously reported denaturation temperatures of 
healthy rabbit corneas stored in 20% dextran-500 to be around 70°C[88]. In this study, unwounded 
control corneas (with 4% dextran-500) denatured at approximately 68°C. The lower dextran 
concentration allows tissues to possess a higher water content, which in turn drives down the 
denaturation temperature. Enzyme treatment resulted in significantly lower denaturation 
temperatures of the KC corneas, indicating the weakening of hydrogen bonds which stabilize the 
collagen triple helix. COR, CART and LN ECM treatment restored the denaturation temperatures 
of the treated corneas to the values of unwounded control corneas. This demonstrates that ECM 
treatment is effective in significantly improving thermal stability of weakened corneas. 
    Previous studies indicate that pro-inflammatory genes are associated with keratoconus. 
Balasubramanian SA et al. [90] have reported that several pro-inflammatory markers such as Il-6 
and Tnfα, and enzymes such as matrix metalloproteinase 9 (Mmp9) are elevated in the tear fluids 
of keratoconus patients. More recently, Pahuja N et al. [91] found that inflammatory genes were 
expressed by the corneal epithelium and stromal keratocytes at the corneal cone apex of 
keratoconus patients. Moreover, a marked reduction in consecutive enzymes and proteoglycans 
such as alcohol dehydrogenase (Aldh) [92] and keratocan [93] was found in cultured keratoconic 
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stromal cells. Thus, the pro-inflammatory response along with the alteration of keratocyte 
phenotype plays an important role in the collagen degeneration of the keratoconic stroma. In the 
field of regenerative medicine, ECM components have been shown to impart certain biological 
cues when used as scaffolds, to help with regulating inflammatory response [85] or promoting local 
cell differentiation and maintaining phenotypes [83]. In our current study, we demonstrated that 
ECM treatment is also beneficial to the cellular environment of the corneal stroma. ECM treatment 
significantly down regulated the pro-inflammatory marker Tnfα, enhanced the Aldh production and 
maintained the keratocan and biglycan levels in the ex vivo organ culture corneas. In contrast to 
photochemical crosslinking which causes keratocyte apoptosis and potential damage to the 
endothelium, an ECM based corneal crosslinking treatment which reinforces corneal biomechanics 
while reducing inflammation and helping maintain healthy keratocyte phenotype in the stroma has 
the potential to be of significant value for keratoconus patients.  
3.5. Conclusion 
We studied the crosslinking effects of ECM microparticles in culture media on corneas. ECMs 
from three distinct tissue types - cornea, cartilage and lymph nodes - all significantly enhanced 
corneal biomechanics, thermal stability and reduced swelling. However, ECMs from different 
organs affected corneal ultrastructure and gene expression differently. Thus, in future studies, the 
biological impact of a variety of different tissue sources will be investigated. In summary, we 
demonstrate that ECMs alone can significantly improve corneal biomechanics to provide 
reinforcement for ectatic symptoms in corneas with potential additional biological benefits of 
reduced inflammation and maintenance of healthy phenotypes. These findings demonstrate the 
benefits of tissue-derived ECM microparticles and demonstrate a potential application as biological 




Figure 3.1 Schematic demonstrating ECM treatment and effect on cornea ultrastructure. 
Enzymatically induced corneal weakening and degradation to simulate corneal ectasia followed by treatment 





Figure 3.2 Gross changes observed following ECM treatment. A) Gross pictures of rabbit corneas 
subjected to various ECMs and the effect of treatments on clarity of the corneas. B) OCT images to determine 





Figure 3.3 Changes in fibrillar packing of corneal collagen. Visualization of collagen fibril density of 
unwounded control corneas, enzymatically degradaded KC corneas and ECM treated KC corneas through 
transmission electron microscopy,with accompanying graph showing results of calculation of fibril diameter 






Figure 3.4 Influence of ECM treatment of physical and thermal properties of cornea. A) Visualization 
of collagen fibril density of unwounded control corneas, enzymatically degradaded KC corneas and ECM 
treated KC corneas through transmission electron microscopy,with accompanying graph showing results of 





Figure 3.5 Gene expression of keratocytes after crosslinking. Inflammatory marker Tnfα, keratocyte 
markers Aldh, Keratocan and Biglycan were evaluated among normal, KC and ECM treated corneas. N=6 in 




4. Chondroitin Sulfate-based Biocompatible Crosslinker Restores 
Corneal Mechanics and Collagen Alignment3 
4.1. Introduction 
Corneal ectasia is a corneal disorder characterized by progressive corneal axial thinning, which 
results in irregular astigmatism and decreased vision[94]. The progression of corneal ectasia is 
more rapid in younger patients and greatly impairs vision and quality of life[95]. Corneal ectasia 
may result from corneal diseases, for example keratoconus (KC), or is a complication of 
photorefractive surgery. It is a consequence of disruption of the normal corneal extracellular matrix 
(ECM) composition and organization. More than 75% of the corneal stroma is composed of type I 
collagen, with small amounts of collagen types II, III, V, VI, and XI, and various proteoglycans 
(PG), which form parallel fibers organized into orthogonally stacked lamellae[96]. In ectatic 
corneas, complex mechanisms, including abnormal collagenase activity, result in degradation of 
collagen and loss of proteoglycans, characterized by fibril loosening and weakened mechanics[97]. 
Collagen crosslinking is an effective method to slow or halt the progression of corneal ectasia; for 
example, riboflavin 5’-phosphate (RF) sodium (Photrexa, Avedro, Inc, Waltham, MA, USA) 
crosslinking[98] was recently approved by the FDA as a clinical treatment for keratoconus. This 
system uses ultraviolet-A (UVA) irradiation to initiate a radical reaction with RF. Riboflavin 
generates free radicals with UVA irradiation and initiates the formation of carbonyl-based covalent 
bonds within collagen fibrils and proteoglycans. Numerous studies have demonstrated that collagen 
crosslinking improves vision quality and slows disease progression[99]. However, UVA irradiation 
                                                     
3 Text and figures in this chapter reprinted from Investigative Ophthalmology and Visual Science, X. Wang, S. 
Majumdar, et al. G. Ma, J. Sohn, S.C. Yiu, et al., Chondroitin Sulfate-based Biocompatible Crosslinker Restores Corneal 
Mechanics and Collagen Alignment, (2017). This work is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit 
http://creativecommons.org/licenses/by-nc-nd/4.0/ or send a letter to Creative Commons, PO Box 1866, Mountain View, 
CA 94042, USA. 
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can cause clinical complications, such as keratocyte apoptosis, temporary corneal haze, and, in 
more serious cases, corneal melting and permanent corneal scarring[75]. Alternative treatments 
now aim to avoid UV light exposure to the eye. These include rose Bengal-green light 
crosslinking[100] and core protein decorin crosslinking that does not require any light 
exposure[101].  
Collagen based biomaterials also frequently require structural reinforcement through chemical 
crosslinking. Small molecule chemical crosslinkers, such as paraformaldehyde and glutaraldehyde 
are highly efficient but are also toxic. Their use necessitates additional biomaterial processing steps 
to ensure complete elimination of these toxic crosslinkers before application in biological systems 
or for internal use. Carbodiimide bioconjugation, involving 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS), is also widely used in the 
biomaterials community[102]. The NHS group interacts with the carboxyl group of the target 
molecule and can then react with amine groups.  
Proteoglycans play an important role in collagen fibril formation and lamellar assembly during 
corneal development[103]. They are composed of glycosaminoglycan (GAG) chains and core 
proteins. Chondroitin sulfate is one of the most abundant GAGs in the natural extracellular matrix 
throughout the body, with various biological functions, such as regulating inflammation[104], 
reducing collagenase activity[105], and controlling collagen fiber spacing in the cornea[106]. 
Chondroitin sulfate is frequently incorporated into biomaterials with collagen[107] or gelatin[108] 
to fabricate scaffolds for cartilage or corneal substitutes[108,109]. Contact lenses that had CS 
loaded into them enhanced healing of corneal lesions[110], purportedly through collagen 
fibrillogenesis. In this study, CS was functionally modified with a highly reactive amine group, 
which was then used in conjunction with NHS to form crosslinks with collagens and proteoglycans 
present in the cornea. This crosslinking process creates strong covalent networks that ultimately 
stabilize the corneal structure without the use of UV radiation or other radical-initiated chemical 
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reactions. The CS crosslinker was applied to an ex vivo corneal ectatic model developed in the lab, 
and the resulting biological and structural changes were evaluated. 
4.2. Methods 
4.2.1. Synthesis of Amine-Reactive Chondroitin Sulfate 
CS-NHS was synthesized as described previously[111]. Briefly, 10% CS (w/v) (25 kDa, New 
Zealand Pharmaceuticals Ltd, Palmerston North, New Zealand), 67% EDC (w/v), and 25% NHS 
(w/v) were combined in a 7:1.5:1.5 (v/v) ratio of CS:EDC:NHS in phosphate-buffered saline (PBS) 
and allowed to react for 10 min at 37 °C. The mixture was flash frozen to -80 °C and then subjected 
to several rounds of extensive washing with -20 °C ethyl alcohol (EtOH). The final CS-NHS 
product was dried under argon gas flow for 2 h and subsequently placed in a vacuum desiccator 
overnight. 
4.2.2. Corneal Ectatic Model and Crosslinking 
  One hundred and forty-four fresh albino rabbit eyes (Cat. #41211-2) in Dulbecco’s 
Modified Eagle Medium (DMEM) were purchased from PelFreez Biologicals (Rogers, AR, USA). 
Corneas with no treatment (normal) were maintained in DMEM for further crosslinking and 
characterization. Other corneas were treated with an enzymatic digestion solution for 1 h at 37 ℃ 
to create a model for KC. The digestion solution contained 10 U/ml collagenase type II (LS004177, 
280 U/mg, Worthington Biochemical Corp, Lakewood, NJ, USA) and 0.1 U/ml chondroitinase 
ABC (C36675U Sigma Aldrich, St Louis, MO, USA) in PBS. The digestion was halted by rinsing 
the corneas in DMEM with 10% fetal bovine serum (Gibco, Thermo Fisher Scientific, Waltham, 
MA) multiple times.  
Normal corneas were crosslinked by submersing the anterior segment (placing the whole eye globe 
upside down) in 2, 5, or 10 mg/ml CS-NHS (CS2, CS5, and CS10) solutions at room temperature 
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for 30 or 60 min. The KC model corneas were crosslinked in 5 mg/ml CS-NHS solution for 60 min. 
For comparison with other crosslinking techniques, normal and KC model corneas were pre-
saturated for 20 min in a 0.1% RF, 15% dextran-500 (Sigma Aldrich) and crosslinked using a 365 
nm UVA light source (F15T8/BL lamp) at 3 mW/cm2 for 30 min. One drop of RF was 
supplemented every 10 min.  
4.2.3. CS-NHS Penetration into Corneal Tissue 
  To track the depth of penetration of CS-NHS into the corneal stroma, the CS-NHS 
molecule was labeled with tetramethylrhodamine-PEO3-amine (TAMRA-PEO3-amine) (Biotium, 
Inc, Freemont, CA, USA) dye by mixing 10% CS-NHS and TAMRA-PEO3-amine in PBS in a 1:1 
molar ratio for 5 min. CS-NHS-TAMRA was washed with -20 °C EtOH and dried under argon. 
The anterior region of each eye globe was immersed in 2 mg/ml TAMRA dye-only solution 
(background control) for 30 min, or varying concentrations (2, 5, or 10 mg/ml) of CS-NHS-
TAMRA solution for 60 min (n=3 for each test condition). Corneas were subsequently rinsed 
repeatedly in PBS to minimize non-specific binding of the dye. Penetration of CS-NHS-TAMRA 
was observed through fluorescent confocal microscopy (Zeiss LSM 510, Carl Zeiss AG, Jena, 
Germany). The mean fluorescent intensity was calculated by subtracting the background control 
intensity at 100 µm depth. The Z-stacking step size was set at 25 µm/section. Penetration depth 
was calculated by adding the number of Z sections with higher fluorescent intensity compared to 
the background control.  
4.2.4. Corneal Swelling Ratios 
Normal, CS2, CS5, and CS10 corneas were stored in 15% dextran-500 PBS solution overnight 
prior to measurement (n=6 for each test condition). An 8-mm biopsy punch was used to extract the 
central corneal button. Corneal buttons were weighed and then transferred to PBS. Change in 
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weight due to swelling caused by water uptake was recorded every 30 min, up to 120 min. The 
swelling ratio was calculated using the equation:  
q=Ws/Wo, 
where Ws represents the weight after swelling and Wo represents the original weight before 
swelling.  
4.2.5. Transmission Electron Microscopy (TEM) 
After enzyme treatment and crosslinking, cornea samples were stored in 15% dextran-500 
overnight before fixation. Samples were fixed in 3% paraformaldehyde, 1.5% glutaraldehyde, 5 
mM MgCl2, 5 mM CaCl2, 2.5% sucrose, and 0.1% tannic acid in 0.1 M sodium cacodylate buffer, 
pH 7.2, overnight at 4 °C. They were post-fixed in 1% osmium tetroxide. Samples were stained 
with 2% aqueous uranyl acetate, dehydrated through treatment in increasingly concentrated 
ethanol, and then embedded in Eponate 12 (Ted Pella, Inc, Redding, CA) resin. Thin sections were 
cut and grids were stained with 2% uranyl acetate in 50% methanol and visualized with a 
Philips/FEI BioTwin CM120 TEM at 80 kV. Image analysis was carried out using MATLAB 
(MathWorks, Inc, Natick, MA) as described previously[88]. Original images were binarized using 
an adaptive thresholding method. Fibril diameter and density were estimated within a randomly 
localized window (300 x 300 dpi). The number of fibers per unit area was measured and recorded. 
We repeated this random procedure 200 times and estimated the density of fibers using the median 
number. 
4.2.6. Live-Dead Staining 
Fresh corneas (3 corneas in each group) were dissected and submersed in PBS, 2, 5, and 10 mg/ml 
CS-NHS, respectively, for 60 min. Positive control corneas were treated with standard RF-UV 
crosslinking as described previously in “Corneal Ectatic Model and Crosslinking”. After treatment, 
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the corneas were stained with LIVE/DEAD® Viability/Cytotoxicity Kit (Thermo Fisher Scientific 
L3224) according to standard protocol. The samples were extensively washed in PBS for 5-8 times 
to minimize background fluorescence in the stroma. Corneas were laid flat with epithelium layer 
facing down, mounted with PBS, and imaged using Zeiss Inverted Fluorescence microscope.  
4.2.7. Hematoxylin and Eosin (H&E) Staining  
Normal, KC model, UV-crosslinked KC model (KC-UV), and 5 mg/ml CS-NHS-crosslinked KC 
model corneas (KC-CS5) were stored in 15% dextran-500 overnight to minimize swelling, and then 
fixed overnight with 10% formaldehyde, followed by graded dehydration with 70% to 100% 
ethanol, and embedded in paraffin. Sections (5 μm) were cut and stained with H&E (Sigma Aldrich) 
according to standard protocol.   
4.2.8. Tensile Testing 
Uniaxial tensile testing was carried out on a Bose EnduraTEC ELF3200 (Bose ElectroForce, 
Framingham, MA, USA) to determine the stress-strain behavior of the corneas before and after 
crosslinking. All test samples for tensile testing were stored in 15% dextran-500 solution overnight 
to minimize swelling. Corneas (n=6 in each test group) were cut into strips of around 5 mm each, 
and the exact width and thickness of each strip was recorded. The corneal strip ends were affixed 
to the clamps on the tensile tester using super glue to avoid slippage. Load and displacement 
measurements were recorded by WinTest software (TA Instruments, New Castle, DE, USA).  
4.2.9. Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction 
Immediately following enzyme digestion for KC model corneas and treatment via crosslinking, 
corneas (n=6 for each test condition) were flash-frozen in liquid nitrogen and ground using pre-
cooled ceramic mortars and pestles. The powdered corneal tissue samples were treated with TRIzol 
(Thermo Fisher Scientific) and total RNA was collected using the RNeasy Mini Kit (Qiagen, Venlo, 
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The Netherlands). The mRNA was quantified using a Nanodrop-1000 spectrophotometer (Thermo 
Fisher Scientific), and then reverse-transcribed using a High Capacity cDNA Kit (Thermo Fisher 
Scientific). Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction (Q-RT-
PCR) was performed with the SYBR Green qPCR Master Mix (Applied Biosystems), and 
expression levels were normalized using the housekeeping gene Gapdh. The primers of the targeted 
genes are listed below.  
Gapdh forward: 5’-CTCTGGAGTGGATGTT-3’,  
Reverse: 5’-CCATGGGTGGAATCATACTG-3’;  
Tnfα forward: 5’-GTAGTAGCAAACCCGCAAGT-3’ 
Reverse: 5’-GGTTGTCCGTGAGCTTCAT-3’ 
Mmp9 forward: 5’-AGTACCGAGGAAAGCCTACTT-3’  
Reverse: 5’-TGCAGGATGTCAAAGTCTAC-3’ 
Aldh forward: 5’-GACGATAACTGCAGAGCACG-3’ 
Reverse: 5’-ACTCATTCGACAAGCAGACAG-3’ 
Biglycan forward: 5’-GCATCCCCAAAGATCTGCC-3’ 
Reverse: 5’-CAACTTGGAGTATCGGAGCAG-3’ 
4.2.10. Statistical Analysis 
Student’s t-test was used to statistically examine differences between normal corneas and cross-
linked corneas in terms of collagen fibril diameter and fibril density. Swelling ratio, Young’s 
modulus, and gene expression were analyzed with Prism 6.01 software (GraphPad Software, Inc, 
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San Diego, CA, USA) using one-way analysis of variation (ANOVA). All experiments were 
repeated twice, with n=6 corneas in each experimental group. P-values <0.05 were considered 
statistically significant. 
4.3. Results 
4.3.1. CS-NHS Penetration into the Cornea  
As CS is a large molecule (~25 kDa molecular weight), it was important to validate its 
penetration capability into the corneal stroma before assessing its crosslinking efficacy. The -NHS 
group in CS-NHS and the amine group in the fluorescent dye TARMA react to form the TAMRA-
labeled CS-NHS entity (Figure 4.1A), which allows visualization of the penetration depth and 
intensity of CS-NHS in the corneal stroma. Corneas treated with CS-NHS-TARMA had a clear 
fluorescent band. The fluorescent intensity was stronger with longer treatment durations and higher 
CS-NHS concentrations (Figure 4.1B). The mean fluorescent intensity at 100 µm in stroma 
increased significantly with crosslinking time and concentration (Figure 4.1C). At 60 min of 
crosslinking, the penetration depth reached up to 275 μm (2 mg/mL crosslinker), 375 μm (5mg/mL 
crosslinker), and 400 μm (10 mg/mL crosslinker) respectively (Figure 4.1D), with an average total 
corneal thickness of over 700 µm resulting from swelling. 
4.3.2. Impact of CS-NHS Crosslinking on Corneal Swelling and Biomechanics  
CS-NHS reacts with amine groups in collagen and proteoglycans in the cornea, forming crosslinked 
covalent networks (Figure 4.2A). Therefore, the effectiveness of the crosslinking treatment can be 
estimated by differences in corneal swelling ratios. The decrease in corneal swelling ratios after 
CS-NHS treatment indicated that CS-NHS was able to effectively crosslink corneal ECMs (Figure 
4.2B). A 30-min treatment with 2 mg/ml and 5 mg/ml CS-NHS slightly reduced the swelling ratio, 
while a 15% decrease in swelling ratio was observed with 10 mg/ml CS-NHS treatment. A 60 min 
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crosslinking treatment with CS-NHS significantly decreased the swelling ratio in all treatment 
groups. A decrease in swelling ratio of up to 35% in CS5 and CS10 groups was observed (Figure 
4.2C). To further characterize the enhancement of corneal mechanics through corneal crosslinking, 
Young’s modulus of treated and untreated corneas was evaluated by tensile testing (Figure 4.2D). 
After 60 min of crosslinking treatment, CS5 and CS10 groups demonstrated significantly higher 
Young’s moduli that was up to 20% greater than groups that did not receive crosslinking treatment.  
4.3.3. Normal Corneal Ultrastructure After Crosslinking  
Normal corneas were crosslinked to determine the optimal treatment time and crosslinker 
concentrations. Following CS-NHS crosslinking, treated corneas exhibited larger fibril diameters 
and densities compared to normal corneas (Figure 4.3, Table 4.1). The formation of a tighter 
covalent network after CS-NHS crosslinking increased fibril density when compared to normal 
corneas. CS5 and CS10 crosslinking demonstrated a significant increase in fibril density, even at 
lower crosslinking durations (30 min). Following crosslinking for 60 min, CS5 and CS10 groups 
also presented a larger mean fibril diameter of 55±13.40 and 59±11.56 nm, respectively, compared 
to 44.24±11.89 nm in the untreated normal group. Overall, higher crosslinker concentrations and 
crosslinking time significantly increased fibril diameter and density. The morphological and 
mechanical data taken together suggest that CS5 (60 min) crosslinking provided significant 
mechanical reinforcement, while minimally changing the collagen fibrillar dimensions compared 
to the native cornea. Therefore, CS5 was chosen as the optimal crosslinking condition for treatment 
of KC model corneas. 
4.3.4. Cell Viability in CS-NHS Crosslinking 
Corneal cells maintained viability after 60 min of crosslinking with few apoptotic cells (Figure 4.4, 
red arrow) in all CS-NHS crosslinking concentrations used, as evidenced by qualitative live-dead 
staining. No visible difference among 2 mg/ml, 5 mg/ml, and 10 mg/ml CS-NHS crosslinking 
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concentrations was observed, and there were no significant differences in cell viability compared 
to non-crosslinked cornea controls. Only positive dead cell staining was presented in RF-UV 
corneas due to the autofluorescence of riboflavin in 488 nm channel. The positive control 
demonstrated considerable cell apoptosis compared to the rest of the groups.  
4.3.5. Ectatic Corneal Morphologies and Biomechanics Following CS-NHS 
Crosslinking 
The efficacy of CS-NHS crosslinking versus the gold standard UV crosslinking was evaluated 
in an ectatic cornea model. KC model corneas exhibited damaged lamellar structures after enzyme 
treatment. Following CS-NHS crosslinking treatment, the corneas recovered the compact stromal 
structure seen in native tissue (Figure 4.5A, B). No major histological differences were observed 
between UV and CS-NHS crosslinked explant corneas (Figure 4.5A).  
TEM imaging (Figure 4.5B) corroborated that collagen fibers in KC model corneas were 
disrupted, with decreased fiber diameter and increased interfibrillar spacing. Treatment with CS-
NHS and UV increased collagen fibril density and restored lamellar spacing. Analysis of TEM 
images of ectatic corneas demonstrated the efficacy of UV versus CS-NHS crosslinking. The 
standard 30 min UV irradiation increased collagen density with no significant change in fibril 
diameter. On the other hand, 60 min of 5 mg/ml CS-NHS crosslinking increased corneal collagen 
fibril diameter and density (Table 4.1).  
Stress-strain curves from uniaxial tensile testing demonstrated that, on average, KC model corneas 
had a 40% lower Young’s modulus value when compared to normal corneas. Efficacy of UV 
crosslinking and CS-NHS crosslinking was comparable and both treatments increased the Young’s 
moduli of KC model corneas by approximately 40% (Figure 4.5C, D). 
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4.3.6. Keratocyte Gene Expression After Crosslinking 
Maintaining keratocyte phenotype without triggering proinflammatory gene activation is important 
to minimize clinical complications, such as corneal haze and scarring. The proinflammatory genes, 
Tnfα and Mmp9, as well as the keratocyte marker genes, Aldh and Biglycan, were evaluated in ex 
vivo rabbit corneas after UV, and CS-NHS crosslinking (Figure 4.6). Enzyme treatment (KC) did 
not significantly affect inflammatory gene expression, however it downregulated keratocyte marker 
expression. UV crosslinking substantially upregulated inflammatory gene production Tnfα and 
Mmp9 in both normal and KC model corneas. Conversely, CS-NHS crosslinking did not upregulate 
Tnfα expression, and, moreover, significantly down-regulated Mmp9 expression. Both UV and CS-
NHS crosslinking enhanced Aldh expression in KC model corneas. Crosslinking and enzyme 
treatment reduced Biglycan expression, but CS-NHS crosslinking preserved higher Biglycan 
expression as compared to UV crosslinking in KC model corneas (Figure 4.6). Therefore, CS-NHS 
crosslinking induced less inflammation and better preserved keratocyte phenotype when compared 
to UV crosslinking.  
 
4.4. Discussion 
UV light-initiated corneal crosslinking, the leading clinical strategy to delay or even halt 
keratoconus progression[112], utilizes photo-generated free radicals to strengthen intrafibrillar 
binding within collagen fibrils[112]. However, the cytotoxicity owing to extended periods of UV 
irradiation causes keratocyte depletion and can also potentially harm corneal endothelial 
cells[113,114]. Glycosaminoglycans, such as CS, have been proved to provide biological benefits 
in corneal tissue engineering, such as promoting corneal wound healing[110]. Therefore, CS was 
designed to be the backbone of the biocompatible crosslinker by modifying it with -NHS, an amine-
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reactive moiety, which allowed us to apply CS-NHS for collagen fibril crosslinking in animal 
corneas.  
Corneal ectasia causes stromal thinning, resulting in weakening and distortion of the underlying 
stromal collagen ultrastructure[69]. Therefore, a major indicator for successful crosslinking is the 
restoration of the collagen fibril arrangement and spacing in diseased corneas[115]. The mechanism 
of UV crosslinking has been reported to be mostly intra-fibrillar, as evidenced by previously 
reported small and wide angle X-ray scattering results, demonstrating no changes to interfibrillar 
spacing after crosslinking., Thus, crosslinking occurred predominately at the collagen fibril surface 
and in the protein network surrounding the collagen[116]. UV crosslinking slightly increased fibril 
diameter, but did not reduce swelling ratio[116]. In our present study, after 60 minutes of CS-NHS 
crosslinking, the swelling ratio was reduced and more importantly, when carried out with high 
crosslinker concentrations, collagen fibril diameter and fibril density were significantly increased. 
This indicates that with multiple -NHS functional groups on a single CS chain, crosslinks between 
CS-NHS and collagen fibrils occur at both intrafibrillar and interfibrillar levels.  
Our previously established KC model[88] demonstrated that controlled enzymatic treatment of the 
corneal ECM triggers collagen fibril degradation, resulting in an increase in interfibrillar spacing 
and corneal thinning. The KC model corneas also showed lamellar undulations representing 
disruption in corneal collagen organization, mimicking physical and ultrastructural changes in 
severely ectatic corneas. Tissue stiffness of normal corneas increased significantly after 
crosslinking with CS-NHS, particularly at high crosslinker concentrations. CS-NHS crosslinking 
also largely ameliorated the loss of mechanical integrity of enzymatically weakened KC model 
corneas, as observed via mechanical testing. Therefore, covalent crosslinking at the fibrillar level, 
which decreases interfibrillar spacing and increases fibril diameter, led to an increase in bulk 
stiffness. Histological analysis confirmed that increase in fibril thickness and tighter packing of 
collagen fibrils resulted in corneal densification, as evidenced by change in the gross thickness.  
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Since the reinforcement of corneal biomechanics is the overarching goal of corneal crosslinking, it 
was important to compare CS-NHS crosslinking with traditional UV-based crosslinking, which 
demonstrated some of the same outcomes[115]. UV and CS-NHS crosslinking treatments on KC 
model corneas resulted in a statistically significant increase in tissue stiffness compared to untreated 
KC model corneas. Moreover, the difference between efficacy of treatment between UV and CS-
NHS crosslinking was not significant. 
Nevertheless, any improvement to mechanical stability or vision is of no clinical value if the safety 
of the treatment is not ensured. Although keratoconus is generally considered a noninflammatory 
disease, previous studies have shown that the levels of degradative enzymes, such as Mmp9, were 
elevated in keratoconic corneas[117]. Moreover, UV crosslinking also triggers pro-inflammatory 
cytokine production, including Tnfα, which affects cell signaling in corneal stroma and eventually 
induces keratocyte apoptosis and, in severe cases, permanent corneal scarring[118,119]. We 
therefore examined the expression of proinflammatory markers Tnfα and Mmp9, as well as key 
keratocyte markers Aldh and Biglycan in normal and KC model corneas subjected to the different 
crosslinking techniques. UV crosslinking treatment in both normal and KC model corneas elicited 
drastic Tnfα and Mmp9 upregulation, direct evidence of the inflammatory response caused by UV 
irradiation. In comparison, CS-NHS crosslinking did not show upregulation of these inflammatory 
markers and, in fact, elicited a downregulation of Mmp9. Furthermore, CS-NHS crosslinking was 
able to protect the keratocyte phenotype by maintaining Aldh expression. Biglycan was 
downregulated in all crosslinked and KC model groups, but CS-NHS crosslinked corneas had 
higher Biglycan expression in comparison to UV crosslinked corneas. The gene expression results 
demonstrate the biocompatible and potentially protective nature of CS-NHS as a corneal 
crosslinker.  
In summary, CS-NHS provides a safe and effective potential alternative option to treat or prevent 
corneal ectasia. Several caveats to the KC model exist that may preclude its ability to mimic in vivo 
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function and efficacy of CS-NHS crosslinking. Keratoconus is an idiopathic disease and can have 
several potential pathophysiologies. The enzyme-mediated ex vivo model which we utilized to 
characterize crosslinking efficacy presented a loss of mechanical strength, loss of total protein and 
ultrastructural damage, which represented several characteristics of keratoconus. However, this ex 
vivo model still provides an affordable and versatile approach to evaluate new crosslinking methods 
before initiating preclinical animal studies. Additionally, enucleated ex vivo eyes undergo swelling, 
which may impair the epithelial barrier function, allowing deeper CS-NHS penetration. 
Furthermore, CS-NHS also potentially binds to the epithelial layer ECM. Therefore, although the 
study was carried out without epithelial cell removal, the transepithelial penetration of CS-NHS 
needs further examination in vivo. Finally, due to the high reactivity of the –NHS functional group, 
CS-NHS has to be prepared fresh before use and could be challenging to maintain on the eye for 
an extended duration. Future in vivo studies will be designed after careful evaluation of the 
transepithelial diffusion rate and crosslinking efficiency of CS-NHS.  
 
4.5. Conclusions 
The ability to slow corneal ectasia and keratoconus progression should not come at the cost of 
damage or injury to healthy cells in the cornea. To circumvent potential harm from exposure to UV 
in traditional UV crosslinking techniques, we developed a safe and biocompatible crosslinking 
approach that maintains the efficacy standards of the traditional treatment. CS-NHS induced both 
intrafibrillar and interfibrillar crosslinking, promoted lamellar stabilization, restored mechanical 
properties in disease model corneas and reduced proinflammatory gene (Tnfα and Mmp9) 
expression, while maintaining higher levels of keratocyte marker gene expression compared to UV 
crosslinking. In conclusion, the CS-NHS crosslinking technique was demonstrated to be an 
effective tool to repair tissue degeneration in an ex vivo rabbit model, presenting several potential 
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advantages over current and traditional therapies. Future studies of the CS-NHS crosslinking 





Table 4.1 Ultrastructural analysis of corneas before and after crosslinking 
 Fibril diameter (nm) 
Density of fibril (per 
300x300 dpi) 



















KC 45.38±14.66 14.1±0.68* 
KC-UV 30 min 46.42±11.39 19.1±0.97# 
KC-CS5 60 min 50.35±13.74 19.6±1.07# 
Normal group refers to rabbit corneas without any treatment. Data presented as means ± standard 
deviation. Student’s t-test was used to statistically examine differences. 
*p<0.01 compared with the Normal corneas 





Figure 4.1 Chemical design and penetration of CS crosslinker through the cornea. (A) CS-NHS is 
labeled with TARMA dye by covalently reacting with amine groups in TARMA-(PEO)3-amine to track 
penetration depth. (B) Corneal explants were immersed in varying concentrations of fluorescently labelled 
crosslinker for 30 and 60 min to visualize CS-NHS penetration. Image analysis quantified the (C) intensity 
at 100 µm depth (related to concentration) and (D) depth of fluorescently labeled CS-NHS crosslinker. The 






Figure 4.2 Normal corneal swelling and biomechanical properties after crosslinking.  (A) CS-NHS 
reacts with collagen molecules and forms a strong covalent network. (B) The decrease of swelling ratio was 
in direct response to crosslinking time and CS-NHS concentration after 30 min and 60 min of crosslinking; 
(C) the enhancement of corneal biomechanics was demonstrated with Young’s modulus increase after 60 






Figure 4.3 Normal corneal ultrastructures after crosslinking. Crosslinking time and crosslinker 
concentration have significant impacts on corneal ultrastructure. Collagen diameter and fibril density 








Figure 4.4 Cell viability after crosslinking. Keratocyte viability after CS-NHS crosslinking was evaluated 
with live-dead staining. White arrows indicate corneal epithelial cells, dashed arrows indicate keratocytes, 







Figure 4.5 Ectatic corneal morphology and biomechanics after crosslinking. (A) Histological images of 
corneas undergoing different treatments, and (B) TEM images at 9700x magnification of KC corneas after 
crosslinking. Images from left to right represent normal, enzyme treated (KC), UV crosslinked KC (KC-UV), 
and 5 mg/ml CS-NHS treated KC (KC-CS5) corneas. (C) Young’s modulus and (D) stress-strain curves of 
normal and ectatic corneas after crosslinking. N=6 in each group, * refers to p<0.05 compared to normal 





Figure 4.6 Gene expression of keratocytes after crosslinking. Inflammatory markers Tnfα and Mmp9, 
keratocyte markers Aldh and Biglycan were evaluated among normal, KC and crosslinked corneas. N=6 in 





5. Artificial chaperone driven collagen self-assembly to engineer a 
biomimetic cornea implant 
5.1. Introduction 
Collagen is the most common protein found in the body[120]. While present in various chemical 
and physical forms, it serves a critical role as a structural building block in many tissues. Collagen’s 
self-assembly properties allow it to spontaneously form triple helices that can assemble into larger 
fibrils. Further organization of collagen fibrils, such as parallel alignment, provides additional 
mechanisms for controlling mechanical properties that can also impact biological 
responses[121,122,123]. Fibril diameter alone can impact cell adhesion, migration and 
phenotype[36]. These structural features and self-assembly properties of collagen can be leveraged 
to create biomaterials with unique physical and biological properties for studying cell-matrix 
interactions and for engineering functional biomaterials. 
In the cornea, collagen has a particularly unique structural and functional organization that is 
responsible for creating a transparent tissue[18]. Collagen fibrils found in the cornea have a small 
diameter (30-35 nm) and these fibers are aligned in parallel in sheets or lamellae, each 2 µm 
thick[124]. Furthermore, the parallel alignment of the collagen fibrils in each lamella run 
orthogonal to adjacent layers, providing anisotropic mechanical integrity. The lamellae and 
collagen fibrils are spaced in a highly regular arrangement, that allows light to pass through the 
tissue without scattering or diffraction[125,126], creating a transparent structure that serves as the 
window to the eye[20,43]. The complex matrix organization in the cornea is formed during 
embryological development. SLRP chaperones such as decorin, biglycan and lumican bind 
collagen and guide the self-assembly process by maintaining collagen alignment and 
spacing[127,128,129]. When the adult cornea is damaged, local biological cues drive repair 
mechanisms and rapid collagen extracellular matrix formation. Without molecular chaperones 
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guiding matrix assembly, the original lamellae and aligned collagen structures of the cornea cannot 
reform. Instead, scar tissue develops after injury, which is not transparent and impairs vision.  
There is a significant clinical need to create corneal substitutes as an alternative to human cadaveric 
transplantation. While in many respects a successful surgery, allograft corneal transplantation 
requires donor tissue and suffers from slow, chronic mechanical failure and immune rejection. 
When transplantation fails, as in up to 70% of cases in high-risk patients with vascularization or 
previous transplant rejection history[5,6,7,8], few alternatives exist today. Early attempts to create 
an off-the-shelf cornea substitute utilized synthetic polymers such as poly (methyl methacrylate) 
and poly [2-hydroxyethyl methacrylate]. Cornea implants derived from these synthetic materials, 
however, do not integrate with the surrounding tissue, stimulate inflammation with 
neovascularization, and are often ultimately extruded from the eye through a process called corneal 
melting[22]. More recently, biological corneal substitutes have been synthesized from 
collagen[24,26,29,130,131]. These collagen implants are more biocompatible than synthetics but 
generally lack structural organization and thus functional properties of native tissue. Without the 
native corneal structure, it is challenging to simultaneously achieve both the mechanical properties 
adequate for suturing and the transparency for vision. Methods to concentrate collagen can produce 
orthogonal lamellae similar to the native tissue[27,28,132,133] but the materials do not reach the 
thickness of the human cornea relevant for clinical transplantation. 
Here, we create a collagen-based biomaterial implant that mimics the native cornea structure and 
demonstrates functionality as a corneal patch. Artificial chaperones, in the form of cyclodextrins 
(CD), were combined with collagen gels[134] in a vitrification process[32,34,35,135,136], to 
promote and guide fibril formation and assembly into parallel aligned, orthogonal lamellae similar 
to tissue development. Biocompatibility and surgical performance of the biomimetic CD/collagen 




5.2.1. Synthesis of CD/Col corneal implants via vitrification 
Equal volumes of 5 mg/ml pH 3 acid solubilized Type I collagen solution and CD solution, 
containing 20 mM HEPES buffer at pH 11 were mixed at 4ºC and poured into hydrophilic culture 
dishes. The solution was then incubated at 37ºC and 5% CO2 for 2 hours to complete gelation. The 
resulting gel was then placed in a sterile humidifying chamber (vitrifier) at 5ºC and 40% relative 
humidity (RH) for 1 day. Gels were further dehydrated in a second vitrifier at 40ºC and 40% RH 
for 1 week to form transparent, rigid vitrigel materials. The resultant vitrigel materials were 
rehydrated in DPBS overnight to form transparent, flexible, robust hydrogels prior to 
characterization, cell culture or in vivo application.  
5.2.2. Electron microscopy (EM) 
Samples were fixed in 3% paraformaldehyde, 1.5% glutaraldehyde, 5 mM2, 5 mM CaCl2, 2.5% 
sucrose, and 0.1% tannic acid in 0.1 M sodium cacodylate buffer, pH 7.2. After buffer rinse, 
samples were post fixed in 1% osmium tetroxide for 1 h on ice in the dark. Following a rinse with 
distilled water, the samples were stained with 2% aqueous uranyl acetate (0.22 µm filtered) for 1 h 
in the dark, dehydrated using a graded series of ethanol, and embedded in Eponate 12 resin (Ted 
Pella, Redding, CA). Samples polymerized for 2–3 days at 37°C and were stored at 60°C overnight. 
Thin sections, 60-90 nm, were cut at a depth of 50 µm from the surface with a diamond knife using 
a Reichert-Jung Ultracut E ultramicrotome and placed on naked copper grids and were stained with 
2% uranyl acetate in 50% methanol, and observed using a Philips CM120 TEM at 80 kV. SEM 
samples were fixed as described above and affixed to SEM stubs. A Leo FESEM was used to 
observe the samples. Lamellar thickness was determined using Image-J software for Windows (US 
National Institutes of Health, Bethesda, MD) on the TEM and SEM photomicrographs. 
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5.2.3. Atomic Force Microscopy (AFM) 
Dried and rehydrated Vitrigel samples were imaged by AFM. All data presented here have been 
acquired on a commercial Cypher S system (Asylum Research, Santa Barbara, CA, USA) under 
ambient conditions. Commercially available silicon nitride cantilevers with a nominal resonance 
frequency of 70kHz (AC240TS-R3, Olympus, Tokyo, Japan) were used. Each probe was 
individually calibrated for spring constant and sensitivity using the Sader method[137]. Typical k 
values ranged between 0.9nN/nm and 1.10nN/nm.  
Imaging was conducted in intermittent contact mode (AC or “tapping”), in Amplitude Modulation 
(AM) mode. The phase was left to vary freely. The cantilevers were oscillated at 7.0-8.5nm, with 
a work to free amplitude ratio, A/Ao, kept between 0.8 and 0.9, in order to minimize damage to the 
gels’ surface. Under these operating conditions, the net dominant forces experienced by the 
oscillating cantilever are attractive. Local force variations can be visualized as a phase shift, where 
a larger attractive force leads to a larger phase shift[138]. Image analysis was performed using 
IgorPro (WaveMetrics, Lake Oswego, OR, USA). 
5.2.4. Physical characteristics measurements 
Transparency was measured by placing fully rehydrated materials on 24-well plates, using the area 
scanning modality on a Biotek Synergy 2 microplate reader in the visible light wavelength range 
of 300-700 nm with 50 nm intervals.  
Tensile testing was performed on hydrated materials using dog-bone shaped tensile test strips, each 
5mm in width. Digital Vernier calipers were used to measure the individual thickness of the CD/Col 
materials between two glass slides. Thickness was measured at six different points for each sample. 
CD/Col materials were then loaded onto a Bose EnduraTec (Minnetonka, MN) mechanical tester 
and stretched at a speed of 0.02 mm/s using a 225 N load cell for native cornea, and 250g load cell 
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for CD/Col materials. To maintain hydration, the hydrated samples were saturated with PBS prior 
to load application. Load vs displacement values were obtained and fracture strain was recorded. 
Stress-strain curves were calculated using Microsoft Excel.  
Rheology was performed with an Ares G2 rheometer (TA Instruments New Castle, DE). 
Experiments were conducted at physiological temperatures (37°C). Eight mm diameter samples of 
500 µm thickness were loaded on the rheometer stage (8 mm geometry, serrated) and axial force 
was set to 1 N. The experimental design followed a frequency sweep from 0.1 Hz to 100 Hz (2% 
strain), strain sweep from 1% to 100% (2 Hz frequency), oscillation time (5 min, 2 Hz, 2% shear). 
Three samples per group, per experiment were tested under the same rheological protocol. Sample 
hydration was maintained using a solvent trap.  
Differential scanning calorimetry (DSC) was performed using a DSC 8000 (Perkin Elmer, 
Waltham, MA) to determine the denaturation temperature of the cornea and CD/Col materials. Pre-
weighed hydrated samples were prepared and placed in aluminum sample pans and crimp-sealed 
with aluminum lids supplied by the manufacturer. Temperature ramp of 5ºC/min over a range of 
10ºC to 90ºC was run. DSC thermograms were analyzed using PyrisSeries Thermal Analysis 
software (Perkin Elmer) version 10.1. 
5.2.5. Biophysical studies on mechanism of CD/collagen binding and ultrastructure 
formation 
UV/Vis absorption was measured by mixing CDs at 0.5 mg/ml in 1 mg/ml acidic collagen solution 
at pH 3. Following mixing, solution was degassed and 1 mL of each solution was pipetted into 
wells of 24 well plates and Biotek Synergy 2 microplate reader was used to measure absorbance of 
wavelengths in the 250-300 nm range.  
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Circular dichroism spectra of collagen solution at 0.125 mg/ml at pH 3, over the range 190-250 nm 
were obtained using Aviv Biomedical spectrometer. Collagen was brought to pH 7 using 20 mM 
HEPES buffer, with or without the presence of CDs at 0.0625 mg/ml. Circular dichroism was 
recorded at 222 nm (absorption bands of the collagen triple helix) for different solutions over a 
temperature gradient of 30ºC to 60ºC. 
A quartz-crystal microbalance (QCM, Qsense E4, Biolin Scientific Inc, Glen Burnie MD) was used 
to detect binding of CDs onto a physisorbed collagen surface.  Collagen at 1 mg/ml in 1 mM HCl 
was adsorbed over pristine gold surface until saturation. Following this, a stable baseline was 
acquired with 1 mM HCl flow, without collagen. Then, CDs dissolved in 1 mM HCl at a 
concentration of 0.44 mM and passed through a 0.22 μm filter, were pumped at flow rate of 0.05 
mL/min through the measurement chambers. Following signal stabilization, pure 1 mM HCl was 
flowed through the chambers again. The instrument was used to record changes in resonance 
frequency (fundamental resonance frequency was 5 MHz, overtones recorded were n = 3, 5, 7, 9, 
11).  
To quantify the βCD binding affinity to collagen molecules, isothermal titration calorimetry (ITC) 
was used. Collagen (5 mg/ml) were dialyzed in 3 liters of 1 mM HCl (pH=3) buffer for 24 hours, 
and diluted to 1 mg/ml with the dialysis buffer. Concentrated βCD at 15mg/ml (13.2 mM) was 
prepared using the same dialysis buffer to avoid generation of any heat of mixing. All binding 
parameters were measured at 20ºC using 1.4 ml of 1 mg/ml collagen sample in the cell titrated with 
25 injections 10 μl 13.2 mM βCD solution each. The injections were separated by 300 seconds. 
The duration of each injection was 12 seconds and the filter period 1 seconds. The stirring speed 
and Feedback Mode/gain option were set up to 300 rpm and high respectively. The sample and 
reference cells were cleaned extensively before each run. Protein solutions were degassed for at 
least 20 min. The isothermal curve was obtained by integration of individual peaks and after 
subtracting the average heat of dilution. Binding parameters were determined from titration binding 
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curves using the one site model from the software MicroCal Data Analysis (Malvern, Westborough, 
MA). 
5.2.6. Cell culture, PCR and biological assays 
Corneal epithelial cells were isolated from fresh rabbit eyes (PelFreez Biologicals, Rogers, AR). 
Excised corneas were incubated overnight at 4°C in 1 mg/ml of Dispase II (Roche) in supplemented 
EpiLife medium (Thermo Fisher). The loosened epithelial sheets were gently scraped off and 
transferred to Accumax (Innovative Cell Technologies, San Diego, CA) at 37°C for 30 minutes to 
disrupt junction proteins, and mechanically agitated followed by filtering through 70 µm cell 
strainer to create a cell suspension. Primary epithelial cells were seeded on CD/Col substrates at 
10,000 cells/cm2 in Human Corneal Growth Supplement (HCGS) supplemented EpiLife medium. 
Cell on various substrates reached confluence by day 5. Confluent cell layer was fixed in 4% 
paraformaldehyde for 15 min, and morphology and marker expressions were observed via 
immunostaining for Mouse anti-human Cytokeratin 14 (K-14) (CHEMMICON) at 1:100, followed 
by secondary staining of 1:100 AlexaFluor594 goat anti-mouse IgG (Life Technologies), and 
counter staining of DAPI (Life Technology)  
Cells were harvested for qPCR at confluence. In brief, epithelial cell layers were washed with PBS 
for 3 times and digested with Accumax for 15 min. Cell suspension was collected and centrifuged 
to form cell pellet. Cell pellet was lysed with 500 µl Trizol (Thermo Fisher) and processed for RNA 
isolation. The mRNA was purified by RNeasy mini kit (Qiagen), quantified by nanodrop and 
reverse transcript by High Capacity cDNA reverse transcription kit (Thermo Fisher). Gene 
expression of epithelial cell markers p63, K3, CX43, were characterized by qPCR. The primer 





Table 5.1 Primer sequences for qPCR 







Forward CTC TGG CAA AGT GGA TGT T 





Forward GGG GGT CGC ATA GGA GTC 






Forward GTC TCA GTC TTC ATA CGG TAA 
C 






Forward TAC ACC TGC AAA AGA GAC CC 





5.2.7. In vivo surgical procedures and post-operative care 
All experimental procedures in this study were performed in accordance to the Association for 
Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Visual 
Research, and were approved by the Institutional Animal Care and Use Committee at Johns 
Hopkins University. Anterior lamellar keratectomy was performed on male New Zealand albino 
rabbits (weight 2.5 - 3.5 kg) under general anesthesia by intramuscular administration of ketamine 
(35 mg/kg of body weight) and xylazine (5 mg/kg of body weight).  Topical anesthesia 
(Proparacaine, Akorn, Lake Forest, IL) was administered on the corneal surface prior to surgical 
procedure. A 6 mm Hessburg-Barron vacuum trephine (Barron Precision Instruments LLC, Grand 
Blanc, MI) and a crescent knife (LaserEdge, Bausch&Lomb, Rochester, NY) were used to remove 
approximately 150 µm of anterior corneal tissue. βCD/Col corneal substitutes (approximately 125 
µm thickness, 6.25 mm diameter and 7.5 mm curvature) were molded to corneal curvature and 
implanted using 12-14 interrupted 10-0 nylon sutures. A mixture of steroid and antibiotic ointment 
(Pred-G, Allergan, Irvine, CA) was applied for 21 days as a post-operative treatment. Gross 
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observations, including ophthalmomicroscopy and fluorescein staining were performed at day 3, 7, 
14, 21 and 31 days after surgery. All animals received the same treatment, therefore no 
randomization was used to determine implant survival in rabbits. Consequently, researchers were 
not blinded. Corneas were harvested at 31 days post-surgery for pathological examinations, fixed 
in formalin and processed for histology. The corneal tissue was removed from the globe, 
dehydrated using graded ethanol solutions and treated with xylene followed by paraffin infiltration. 
Tissue sections were embedded in paraffin blocks and sectioned using a microtome, at 5 µm 
thickness. Sections on slides were then processed for standard histological Hematoxylin and eosin 
(H&E) staining, Masson’s Trichrome staining and for immunohistochemical staining of Rat anti-
Mouse CD11b (BD Biosciences)  
5.2.8. Statistical analysis 
All experimental analyses were performed samples of at least n = 3, representative of two or more 
independent studies. No statistical method was used to predetermine sample size in animals. Data 
are expressed as mean +/− standard deviation and statistical significance (p value) between 
conditions was determined by One-way analysis of variance (ANOVA) with the Bonferroni post 
hoc test using GraphPad Prism 5. 
5.2.9. Data availability 




5.3. Results and Discussion 
5.3.1. CD artificial chaperones modulate collagen self-assembly 
To determine the potential use of CD as a molecular chaperone for collagen assembly, we screened 
CDs with varying size and functionality for their ability to control collagen self-assembly and form 
biomaterials with an architecture similar to the native cornea (Figure 5.1). CDs are circular 
oligosaccharides with varying internal diameter depending on the number of sugars (αCD, βCD, 
γCD) (Figure 5.2a). For example, βCD consists of seven glucopyranoside units creating an internal 
diameter on the order of 0.65 nm (Figure 5.1b). The hydrophobicity of the CD  interior core[139], 
allows the formation of complexes with hydrophobic compounds.  The CD exterior is hydrophilic 
and the base alcohol groups can be replaced with various functional groups such as phosphate(-
PO4), succinyl (-CO-CH2-CH2-CO2H, abbreviated as -S), methyl(-CH3), thiol(-SH), butyl(-C4H9), 
and amine (-NH2). To generate the composite materials, CDs were dissolved in buffer and then 
combined with collagen to form a gel using standard conditions (CD/Col)[35]. The CD/Col gels 
were subsequently vitrified, a process that provides a slow, controlled dehydration under defined 
temperature and humidity conditions that facilitates a gradual concentration of collagen[36]. As 
collagen concentrations increase during vitrification, a nematic liquid crystal phase of collagen can 
be formed that causes molecular crowding effects and ultimately self-assembly Figure 5.3a).  
Incorporation of CD into the collagen gelation and vitrification process produced materials with 
varying ultrastructure depending on the CD size and functionality (Figure 5.3b and Figure 5.2b, 
c). Specifically, fiber diameter, orientation and lamella development depended on the size and 
chemical functionality of the CD. Collagen fibers with visible banding in TEM ranged from barely 
detectable in gels with αCD, βCD, and γCD, to moderately visible in αCD-SH, αCD-NH2, βCD-
C4H9 and readily observable in TEMs of Col, αCD-Suc, αCD-PO4, and βCD-Suc. The orientation 
of the fibers observed by SEM were either randomly oriented (αCD-SH, αCD-PO4, βCD-C4H9, 
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αCD-NH2) or aligned in parallel over large regions (αCD-Suc, βCD-Suc), similar to the native 
cornea. Finally, lamellae of collagen were visible grossly (Figure 5.1d) and in TEM of βCD and 
βCD-Suc containing materials, however the layers were random in thickness, ranging from 0.5 µm 
to 5 µm compared to the native cornea where they are consistently 2 µm. Formulations synthesized 
with αCD-SH and αCD–CH3 did not form structured materials that could be handled and those with 
αCD-PO4 and αCD-NH2 were opaque. Further characterization was then performed only on 
formulations containing αCD, βCD, γCD, αCD-Suc and βCD-Suc, which all produced materials 
that were grossly transparent and could be handled.  
The size and functionality of the CDs incorporated into the collagen gels impacted the bound water 
and thus water evaporation during the vitrification process. While all formulations started with 
similar liquid volumes and concentrations of collagen, the resulting CD/Col materials varied in 
water content (Figure 5.4a), and thus collagen concentration (Figure 5.4b) after vitrification. 
βCD/Col materials had the highest collagen concentration and lowest swelling ratio after 
vitrification, most similar to the native cornea while αCD/Col and γCD/Col had the lowest collagen 
concentration and highest swelling ratio (Figure 5.4a, b). This varying concentrating of collagen 
can thus influence the assembly through molecular crowding effects to produce unique 
ultrastructures. 
Transparency is critical to the functionality of a cornea mimetic and is related to the collagen 
concentration and organization. Collagen materials without CD had the lowest transparency values 
(Figure 5.3c). These implants were thin (~150 µm) and were 88% transparent at 550 nm (average 
wavelength of white light) and only 62% when normalized to a 400 µm thickness. Therefore, 
achieving a minimum functional transparency at a thickness of native human cornea would be 
impossible with these materials. Addition of βCD produced materials with the greatest 
transparency, 77% at 550 nm normalized to 400 µm (Figure 5.3c). However, there was no 
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statistical significance between the transparency of different CD/Col materials (Figure 5.3c and 
Figure 5.4c, d). 
To further evaluate the physical properties resulting from the addition of CD to collagen 
vitrification, we characterized the mechanical properties using a variety of methods. Shear and 
tensile mechanical forces impact the cornea from blinking and the intraocular pressure pushing the 
cornea outwards. Moreover, surgical implantation of a cornea substitute requires tensile strength to 
hold sutures similar to the native tissue. Finally, elasticity is needed to avoid cracking from 
brittleness during suturing and after implantation. Therefore, we tested and compared tensile, 
rheological (viscoelasticity), and compression properties of the implants with CD compared to 
collagen alone and the native cornea. The Young’s modulus (stress/strain) was greatest for the 
collagen gel, however the strain at fracture was the lowest of all of the groups (Figure 5.3d and 
Figure 5.4e, f). This fracture at lower strain suggests lower suture hold strength. Implants 
containing βCD had a similar Young’s modulus compared to the native cornea. The native cornea 
had a greater fracture strain compared to the βCD, but the difference was not significant. Cornea 
and βCD/Col both demonstrated significantly lower Young’s modulus and strain at break than Col 
materials. Viscoelastic properties of the materials, measured by rheology, were significantly 
different between the groups and did not follow the same trends as the tensile properties.  The 
collagen and βCD materials had the greatest storage modulus, or in other words they exhibited the 
ability to store a higher quantity of deformation energy elastically (Figure 5.3e, Figure 5.4g). The 
tan δ (ratio of loss modulus and storage modulus) of βCD and the cornea were similar with no 
statistical difference, and these lower values representing higher elastic component in the 
viscoelastic behavior. Thus, the βCD/Col materials exhibited tensile properties that would support 
suturing, and cornea-like viscoelastic properties. 
To further compare the bulk properties of the CD/Col materials with the native cornea, we evaluated 
the denaturation temperature using differential scanning calorimetry (DSC). The specific heat 
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required to denature βCD/Col and the native cornea were similar and significantly greater than all 
of the other formulations (Figure 5.3f and Figure 5.4h). The higher value of denaturation 
temperature correlates with greater interfibrillar interactions between the collagen fibrils. Taken 
together, these morphological, mechanical, and functional data suggest that βCD/Col materials 
provide the best mimic of the native cornea and satisfy the design criteria of transparency and 
mechanical integrity required for a cornea substitute.  
5.3.2. βCD molecular interactions with collagen 
The bulk properties of the βCD/Col materials suggested a molecular interaction between the CD 
and collagen molecules that impacted assembly. To explore the mechanisms of these interactions, 
we first considered the impact of CD on the collagen secondary structure and fibril formation using 
circular dichroism. The typical collagen triple helix signal in circular dichroism over the 
wavelength spectrum has a positive band at 222 nm and a negative band at 200 nm[140]. Addition 
of CD to a collagen solution increased the stability of the collagen triple helix, measured at 222 
nm, demonstrated by an increased temperature required to induce protein unfolding and 
denaturation (Figure 5.5a, and Figure 5.6a). Further, the addition of CD changed the characteristic 
collagen triple helix curve of a strong negative peak at 200 nm (Figure 5.5b and Figure 5.6b). As 
collagen gelation occurs with neutralization, the characteristic collagen triple helix signal from 
circular dichroism is attenuated as the helices combine to form larger fibrils. Addition of CD 
reduces this signal attenuation suggesting a direct molecular interaction that suppresses fibril 
formation that results in the reduced fibril size that was observed in the SEM and TEM images.   
To determine potential specific interactions between the CDs and collagen molecules, we evaluated 
the UV absorbance of solutions of collagen with αCD, βCD, γCD and βCD-Suc. βCD is known to 
bind with polypeptides[141] containing aromatic groups[141,142] such as tyrosine[143], as 
measured by a shift in wavelength and increase in peak absorbance of the characteristic UV 
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absorbance peak of tyrosine at 275 nm. Collagen was combined with the CDs at pH 3 so no gelation 
would occur and the potential interactions of CD with collagen could be isolated. The UV-Vis 
absorbance profile of collagen increased with the addition of CD, with βCD inducing the largest 
shift (Figure 5.5c and Figure 5.6c). This result suggests that the CD molecules interact with the 
aromatic amino acids in collagen such as tyrosine, phenylalanine and tryptophan. 
CD/collagen binding was further confirmed using Quartz Crystal Microbalance (QCM). Collagen 
was deposited on a gold substrate after which a solution of CD was introduced (dotted line A, 
Figure 5.5d). The resonance frequency of the crystal changes when the mass of the coating 
changes, in this case when CD binds to collagen. Both βCD and βCD-Suc induced a frequency 
change in contrast to a control sucrose solution that cannot bind to collagen. When the CD solution 
is replaced by buffer (Figure 5.5d), the frequency (correlated with adsorbed mass) partially and 
completely returns to the initial levels for the βCD-Suc and βCD suggesting a reversible interaction. 
The reversibility of the CD/collagen interactions was therefore further investigated by evaluating 
the remaining CD in the bulk materials. When CD/Col materials were rehydrated after vitrification, 
an initial burst release of excess CD was observed followed by slow release of more closely bound 
CD quantity over 48 hours (Figure 5.6d).  
The strength of the collagen interaction with βCD was quantified by isothermal titration calorimetry 
(ITC). βCD forms aggregates at concentrations higher than 2-3 mM in neutral and acidic 
solutions[144,145], and titration of a concentrated βCD solution at 13.2 mM into control solution 
(1 mM HCl, no collagen) presented a typical heat of dilution curve seen in an aggregate-monomer 
dissociation model. βCD (13.2 mM) was then titrated against a 1 mg/mL collagen solution in 1 mM 
HCl (pH3). Large exothermic peaks indicate that CDs bind to the collagen and the attenuation of 
the endothermic peaks from control conditions (1 mM HCl, no collagen) confirm that the βCD 
aggregate equilibrium shifts in favor of dissociation, and interaction with collagen (Figure 5.5e). 
The simulated binding affinity was calculated to be 511±27.4 M-1, implying dissociation constant 
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of 1.96±0.10 mM, and the approximate number of binding sites was 10±3 per collagen molecule. 
This is below the estimated number of aromatic amino acids in collagen[146]. 
Following gelation and during vitrification, the CD molecules in the collagen gel concentrate to 
form aggregates as the material dehydrates. These aggregates were visible as hydrophilic regions 
close to collagen fibrils in the phase shift channel of atomic force microscopy (AFM) in vitrified 
materials with CD (Figure 5.7, dry state). However, once rehydrated, the CD aggregates dissolve 
into the rehydration buffer and these regions are no longer observed (Figure 5.7, rehydrated and 
dried state). This implies that the CD aggregations may be responsible for the enhanced structural 
lamellation observed in the CD/Col materials after vitrification. This lamellar configuration is 
preserved even after removal of the excess CD. 
Taken together, the characterization of bulk properties and molecular interactions found that βCD 
binds with tyrosine and other hydrophobic amino acids on collagen with a dissociation constant of 
1.96+0.10 mM (Figure 5.5f). This interaction leads to a reduced fibril diameter during gelation. In 
βCD-Suc, hydrophilic succinyl groups may interfere with the hydrophobic interactions between the 
aromatic groups on collagen and the CD inner core (Figure 5.5g). The succinyl groups may 
potentially also interact with positively charged amino acids, or form hydrogen bonds with other 
amino acids.  The concentration of collagen during vitrification creates a liquid-crystalline phase 
allowing the formation of lamellae. The CD-collagen interaction is reversible and therefore the 
majority of the CD molecules can be removed after assembly. The resulting βCD/Col biomaterial 
has local fibril alignment and organized lamellae that provide increased mechanical strength and 
transparency, with many similarities to the native cornea. 
5.3.3. βCD/Col biomimetic cornea compatibility and surgical performance 
We evaluated corneal epithelial cell proliferation and biocompatibility on CD/Col implants using 
immunocytochemistry and gene expression (Figure 5.8). Primary rabbit corneal epithelial cells 
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proliferated and formed a monolayer on the CD/Col implant materials within 72 hours. Keratin 14 
(K14, epithelial cytoskeleton protein) staining revealed that primary corneal epithelial cells 
maintained epithelial morphology on all materials, and expressed limbal stem cell specific protein 
p63 (Figure 5.8a and Figure 5.9a-g). Gene expression for p63, Connexin 43 (CX43, gap-junction 
protein), and Keratin 3 (K3, corneal epithelium specific cytokeratin protein) were evaluated to 
determine maturity of corneal epithelial cells (Figure 5.8c and Figure 5.9h). Epithelial cell gene 
expression on Col and βCD/Col vitrigels was similar to tissue culture polystyrene (TCPS).  
Epithelial cells on βCD/Col vitrigel expressed significantly higher expression of K3 compared to 
Col vitrigels. Concurrently, epithelial cells on βCD-Suc Col vitrigel presented significantly higher 
expressions of p63 and CX43, indicating maintenance of healthy epithelial cell phenotype and stem 
cell niche on CD/Col materials.  
To translate the βCD/Col materials to applications in corneal repair, curved implants were 
engineered to fit the anterior corneal surface. Custom designed plastic molds were used (Figure 
5.8d) to create lenticular implants (Figure 5.8e). Manufacturing protocols were developed that 
supported homogenous mixing of the CD and collagen along with vitrification in the curved molds. 
Resulting βCD/Col materials were implanted in a partial keratectomy corneal defect surgically 
created in a rabbit model (6 mm diameter, 150 µm depth, n=4) (Figure 5.8f). The βCD/Col implants 
were sufficiently strong to be held in place using simple interrupted sutures. Re-epithelialization 
across the implant and integration with the adjacent host corneal tissue was followed over 31 days 
(Figure 5.8g and Figure 5.10). Progress of epithelial cell migration was observed using fluorescein 
staining on the ocular surface under blue light. Epithelial defects are observed as fluorescent 
regions, while a contiguous healthy epithelium remains unstained. Sutures were removed on day 
21 post-surgery, by which time the implant had successfully integrated with surrounding tissue. 
Over 90% re-epithelialization was achieved by the last time point for the animal study. Masson’s 
Trichrome histological staining of the excised rabbit corneas at day 14 (Figure 5.8h) and day 31 
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(Figure 5.10) demonstrated the presence of the implant and epithelial cell coverage over the 
βCD/Col material. Further, laminin proteins, which are expressed by epithelial cells post-
maturation, were detected on the re-epithelialized implant using immunohistochemistry (Figure 
5.8i and Figure 5.8j). The ability to suture the βCD/Col material, its reepithelialization capacity 
and tissue integration, demonstrates its potential viability as a biomimetic corneal substitute. 
5.3.4. Artificial chaperones for controlling collagen assembly and development of 
functional biomimetic implants 
Tissues throughout the body depend on collagen molecules assembled into complex ultrastructures 
relevant to their required structural and functional properties. Frequently, these tissue architectures 
are established during development and are unable to be recapitulated when damaged in adult 
tissue. Moreover, this complexity in assembly remains challenging to replicate using today’s 
materials science techniques. Here, we demonstrated the use of cyclodextrins as an artificial 
chaperone to assemble collagen during gelation and vitrification. Cornea substitutes were 
engineered using βCD and collagen to achieve an ultrastructure similar to the native cornea with 
transparency and mechanical integrity required for application. Elucidation of the mechanisms in 
self-assembly enables the further application of the artificial chaperones for materials design that 





Figures and figure legends: 
 
Figure 5.1 Cyclodextrin artificial chaperones modulate fibril formation and alignment in vitrified 
collagen cornea substitutes via interactions with collagen. a) Schematic demonstrating cyclodextrin-
collagen binding, ultimately influencing collagen ultrastructural organization and spacing. b) General 
chemical structure of beta-cyclodextrin depicting the 7-sugar cyclic oligosaccharide with modifiable 
functional groups (-R).  c) Gross image of 500 µm thickness implants manufactured using βCD-Suc and 
collagen to demonstrate optical clarity. d) Evidence of macroscale lamellar structures in the implants as 





Figure 5.2 Screening CDs with varying size and functionality for ability to control collagen self-
assembly. a) Molecular structures of the 6-sugar cyclic oligosaccharide α cyclodextrin, the 7-sugar cyclic 
oligosaccharide β cyclodextrin, and the 8-sugar cyclic oligosaccharide γ cyclodextrin. R- represents 
modifiable functional groups. b) Transmission electron microscopy of cross sections of several CD/Col 
materials with different cyclodextrins, during initial screening process to determine notable differences in 
collagen fibril formation and organization. Scale bar = 500 nm c) Scanning electron microscopy (left) and 
transmission electron microscopy (right) images to elucidate ultrastructures of αCD/Col, αCD-Suc/Col and 






Figure 5.3 Cyclodextrin functional groups define collagen fibril organization, transparency and 
mechanical properties. a) Vitrigels manufactured by mixing equal volumes of collagen and CD-buffered 
solution causing gelation and micro-fibrillar assembly followed by fibril growth and reorganization during 
controlled dehydration (vitrification). b) Transmission electron microscopy and scanning electron 
microscopy of Col, βCD, and βCD-Suc and native rabbit cornea, to demonstrate effect of CD functionality 
on collagen ultrastructure organization. Scale bar = 500 nm c) Light transmission over visible light spectrum 
of vitrigel formulations (normalized to 400 µm) with and without incorporation of cyclodextrins, d) Young’s 
modulus and strain at break measurements to monitor tensile properties of vitrigels following cyclodextrin 
incorporation. e) Oscillatory rheological properties of vitrigel formulations with cyclodextrin 
functionalization. f) Differential scanning calorimetry thermograms to determine thermal stability of vitrigels 
following incorporation of CD. Data are means ± SD, n ≥ 3 (representative of at least two independent 
experiments), analysis of variance (ANOVA) with Bonferroni’s post-test [(d) and (e)]: ***P < 0.0001, **P < 




Figure 5.4 Further physical characterization of selected CD/Col materials. a) Swelling ratio determined 
as a ratio between fully hydrated vitrigel weight and weight following lyophilization. b) Theoretical collagen 
concentration in final vitrified product. c) Light transmission over visible light spectrum of vitrigel 
formulations with and without incorporation of cyclodextrins after initial screening, normalized to 400 µm. 
d) Light transmission values of the materials at 550 nm. e) Tensile stress-strain curves of vitrigel strips to 
evaluate elastomeric behavior following CD incorporation. f) Simultaneous comparisons of elastic modulus 
and strain at break for each vitrigel formulation to assess viability as corneal substitutes. g) Oscillatory 
rheological analyses of CD incorporated vitrigels to determine viscoelastic properties, h) DSC thermograms 
to quantify thermal stabilization following incorporation of various CD molecules. Data are means ± SD, n ≥ 
3 (representative of at least two independent experiments), analysis of variance (ANOVA) with Bonferroni’s 






Figure 5.5 Collagen-cyclodextrin molecular interactions and effect on fibril formation. a) Circular 
dichroism spectroscopy among groups to demonstrate changes in thermal stability following molecular 
interactions between soluble collagen and βCD, b) CD spectrum of collagen triple helix with and without 
CD at a temperature of 5ºC. c) Shift in UV-visible light spectrum absorbance peak following incorporation 
of βCD and βCD-Suc into soluble collagen. d) Frequency change associated with βCD and βCD-Suc 
deposition and binding to collagen coated substrate via QCM analyses (frequency overtone n=5). e) 
Quantification of binding affinity of βCD with collagen via ITC at 20ºC. f) Schematic showing interaction 
of collagen hydrophobic groups with hydrophobic inner core of βCD and chemical structure, g) Incorporation 
of βCD-Suc in collagen involves additional interaction of the highly hydrophilic succinyl side chains and 





Figure 5.6 Selected CD/collagen molecular interactions and consequent release from bulk material. a) 
Circular dichroism spectroscopy demonstrates temperature shifts when following interactions of collagen 
with different CDs. b) CD spectrum signal of the characteristic collagen triple helix curve is suppressed to 
various levels with different CDs indicating potentially limited fibril formation. c) CD interacts with collagen 
aromatic groups causing a blue-shift in wavelength and an increase in absorbance peaks, observed in the UV-
visible wavelength spectrum. d) Majority of βCD and βCD-Suc release from vitrified implants on 






Figure 5.7 Topography, amplitude and phase shift response of cornea mimetic material observed by 
AFM for dried and rehydrated samples. Hydrophilic areas (indicated by arrows) close and around collagen 
fibers can be observed in the phase shift channel of the dried samples. These areas, present only in the samples 







Figure 5.8 Cellular compatibility and surgical in vivo performance of biomimetic collagen-CD 
implants. a) Proliferation of primary rabbit corneal epithelial cell on CD/Col materials and staining for K14 
(red) and DAPI (blue) on βCD/Col vitrigels. Scale bar = 20 µm b) Cross-section of in vitro epithelial cell 
culture on βCD/Col with K14 and DAPI staining, c) Custom molds used for manufacturing implants with 
desired curvature. d) Lenticularly shaped βCD/Col corneal implants with curvature of healthy cornea. e) 
qPCR with epithelial cell culture on vitrigels to determine regulation of genetic markers CX43, K3 and P63. 
f) Schematic of in vivo implantation of corneal implant and affixation using interrupted sutures. g) Gross 
images of the in vivo ocular surgery in the rabbit model over 31 days and fluorescein staining (under blue 
light) to monitor progress of reepithelialization over βCD/Col implant. Yellow staining under blue light 
indicates regions of the implant without epithelial cell coverage. h) Histological analysis of sections stained 
using Masson’s Trichrome to visualize implant after 14 days. Scale bar = 100 µm. i-j) Immunostaining for 
laminin (red) and DAPI (blue) in peripheral and central wound regions. Laminin proteins are expressed by 
epithelial cells after maturation. Scale bar = 50 µm. Data are means ± SD, n = 6 (representative of at least 











Figure 5.9 Immunocytochemistry and qPCR of rabbit corneal epithelial cells grown on several 
different CD/Col substrates with staining for K14 counterstained with DAPI as indicated for a) 
αCD/Col, b) βCD/Col, c) γCD/Col, d) αCD-Suc/Col, e) βCD-Suc/Col, f) Col only, g) Tissue culture treated 
polystyrene (TCPS). Scale bar: 20 μm. h) qPCR of key epithelial markers CX43, K3, and limbal stem cell 
marker P63. Data are means ± SD, n = 6 (representative of at least two independent experiments), analysis 





Figure 5.10 In vivo surgical compatibility of βCD/Col implants in rabbits. a) Implantation of CD vitrigels 
as corneal implants via anterior lamellar keratoplasty using interrupted sutures, and observation of healing 
process (gross images) and reepithelialization (using fluorescein dye, under blue light) over 31 days. b) 
Histological sectioning and staining using Masson’s Trichrome to demonstrate survival and integration of 




6. A versatile approach to modulate collagen fibrillogenesis to alter 
optical and biological properties of corneal implants. 
6.1. Introduction 
The cornea is primarily made of collagen and is uniquely transparent owing to a highly organized 
and complex structure. It is an avascular tissue consisting of three major layers: the outermost 
epithelium, the stroma, and the innermost endothelium, which regulates the water content of the 
stromal layer through an active pumping mechanism [147]. The stroma represents over 90% of the 
total cornea, sparsely populated with keratocyte cells and composed mainly of type I collagen 
extracellular matrix molecules and smaller percentages of type V collagen and proteoglycans. The 
corneal stroma also has a unique structural organization of approximately 200 lamellae, each 2-μm 
thick, which contribute to the mechanical strength and transparency of the tissue [18]. Although 
corneal transplants are considered successful surgical procedures for many indications, rejection 
and mechanical failure (non-immunologic loss of corneal clarity over time) are common, especially 
for younger patients and those with ocular comorbidities. Furthermore, the pool of donor tissue is 
decreasing globally owing to the increased rates of surgery for refractive correction. Alternative 
options for repairing corneal injury and scarring are needed, and an off-the-shelf material that 
mimics the native cornea would be transformational. 
Using a collagen vitrification process, we created synthetic corneal implants with increased 
mechanical strength and beneficial cellular interactions compared to standard collagen gels. 
Specifically, collagen membranes with fibrillar structures were developed in collaboration with Dr. 
Toshiaki Takezawa, the inventor of collagen vitrigels [32,33,34]. The vitrification process cures 
collagen gels at a defined humidity and temperature to control water evaporation so that collagen 
macromolecules can organize into fibrils. In collaboration with the Applied Physics Laboratory 
(APL), processing conditions were further optimized to reduce vitrification time and to increase 
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mechanical strength and transparency of the gels [35,136], and exhibit biophysical properties 
superior to standard amorphous collagen gels. Furthermore, the fibrillar structure of the collagen 
vitrigel allowed cultured keratocytes to maintain their in vivo phenotypes (defined by morphology 
and gene expression) more than amorphous collagen gels or tissue culture polystyrene, where cells 
typically became fibroblastic [33,36]. These vitrified collagen membranes also demonstrated 
biocompatibility in vivo in partial corneal defects in a rabbit model [37]. However, these 
membranes were thin (~50 μm), whereas the natural cornea is humans 500 μm. 
The next challenge was therefore to create an implant with a thickness similar to the full-thickness 
cornea. Unfortunately, if we simply extended the vitrification process to larger collagen gels on the 
order of the thickness of the human cornea, the implants would lose clarity due to light scattering 
by the unevenly distributed fibril diameters, lack of fibril alignment, and non-physiological 
interfibrillar spacing. During corneal development, collagen fibrillogenesis is a multiple-step 
process that is tightly regulated by the interaction of many molecules. In this process, small leucine-
rich proteoglycans (SLRPs) bind to the collagen protofibril surface to regulate linear and lateral 
fibril growth during maturation, thus resulting in a “corneal block,” wherein fibril diameters are 
limited and organization occurs in such a way to allow for proper refraction of light and 
transparency [128,148,149,150]. Therefore, we developed a strategy to create a full-thickness 
corneal implant that would have adequate mechanical properties for suturing and maintenance in 
the eye, as well as transparency and biocompatibility. The novel material is based on the 
vitrification of collagen combined with cyclodextrins (CD), which are small cyclic 
oligosaccharides that comprise a family of cyclic oligomers containing a ring of six to eight glucose 
molecules. These ring molecules feature an inner hydrophobic core and an outer hydrophilic ring 
that can form complexes with small molecules or portions of large compounds [151,152]. The CD 
molecules play a role similar to SLRPs during development, chaperoning collagen fibers during 
the vitrification process. CD serves as a proteoglycan substitute by forming specific interactions 
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with the collagen triple helices to control fibrillogenesis, but not fully interrupt fibril formation. CD 
also facilitates the formation of lamellar layers with thicknesses close to that observed in native 
cornea. Here, we propose to develop a library of CD-collagen (CD-Col) materials to characterize 
and understand mechanistically how the biomimetic structure is created and to translate the 
technology in the development of a cornea implant. 
While preliminary in vitro and in vivo experiments demonstrate biocompatibility of the biomaterial, 
there are several challenges that needed to be addressed. The lamellar nature of the CD Col implants 
could allow epithelial migration into the lamellae instead of over the implant. Re-epithelialization 
over the implant may be impaired, which could eventually cause material loss, degradation and 
corneal graft failure. To bolster epithelial cell migration, several strategies may be used including 
material surface modification by chemically crosslinking cell attachment peptides such as RGD, 
and modification of implant design and surgical strategies to better fit or cover the surface. The CD 
Col material formulation also demonstrated surface roughness which could potentially slow down 
epithelial migration speed. While these properties were excellent for a corneal stromal substitute, 
they may not be ideally suited for enhanced reepithelialization. 
Several factors such as pH, temperature and ionic strength help modulate collagen gelation and 
fibril formation. CD-Col materials were originally prepared by increasing the pH of the collagen 
solution to pH 7 by mixing in a buffer, followed by vitrification and rehydration. In this current 
chapter, we aim to influence fibrillogenesis in ‘vitrigel’ biomaterials through alternative gelation 
techniques using ammonia gas permeation, and assess the role of fibrillar networks in optical and 
biological properties and performance in vivo. This dramatically decreases the required starting 
volume of the collagen (no buffer mixing required) as well as decreases the 
vitrification/dehydration time for thicker implants. Additionally, the buffer mixing process could 
amount to some human error and potentially results in formation of bubbles or uneven gelation, in 
addition to being a highly labor-intensive process. The use of ammonia to neutralize acidic collagen 
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solution, allows for a one step process that does not involve mixing of multiple solutions and 
maintains high starting concentration of collagen in the initial mixture. CD can be pre-dissolved in 
the acidic collagen solution as required.  
Previous studies which dealt with gelation of collagen through ammonia vapors expose collagen to 
ammonia for an approximate amount of time until gelation is complete, followed by equilibration 
in buffer, most often for periods of 24 hours or more[153,154]. However, we have delved into 
exploring the effects of ammonia over- and under-exposure on collagen in the formation of gels. 
Moreover, we have studied the biomaterials thus formed in the context of vitrification, following 
the ammonia mediated collagen (AMC) gelation. The changes in exposure time was able to confer 
control over the fibrillar structures formed during gelation. These fibril structures were further 
amplified during the vitrification process and resulted in transparent, strong and flexible sheets of 
collagen. Using the AMC gelation technique, we were able to control the optical properties of the 
collagen biomaterials thus formed. Highly transparent AMC materials were then successfully used 
as corneal transplant materials.  
6.2. Methods 
6.2.1. AMC vitrigel preparation 
Acidic collagen type I (CosmoBio) at 5 mg/mL concentration and pH 3 was used. Specified 
volumes of collagen solution were dispensed into plastic molds maintained at 4°C. In a closed 
chamber, ammonium hydroxide maintained at 25°C was allowed to interact with degassed collagen 
solution. Collagen was exposed to ammonia vapors in desiccation chamber at room temperature 
for 3 min, 30 min and 2 h. Collagen gels were then removed from ammonia chamber and incubated 
in 5°C vitrification chamber for 90 minutes, followed by a 30-minute incubation (gelation) at 37°C. 
Samples were vitrified in a 5°C vitrification chamber overnight followed by a 37 °C and 40% RH 
for 3 days. The biomaterials were then rehydrated in 20 mM HEPES for 24 hours. 
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6.2.2. Second Harmonic Generation Microscopy 
To observe fibrillogenesis of AMC vitrigels, two-photon microscopy was performed using a Zeiss 
LSM-710 microscope (Carl Zeiss, Jena, Germany. Illumination was performed at a wavelength of 
790 nm. Collagen fibrils were detected by its second-harmonic generation (SHG) signal below 480 
nm. Images were recorded as z-stacks overarching the whole membrane with 1 µm Z-spacing using 
Zen software 2009 (Carl Zeiss). 
6.2.3. Light Transmission 
AMC vitrigels were cast in microplate wells, vitrified, rehydrated and measured using a standard 
multi-plate reader Synergy 2 (Biotek). Area scan measurements were made at over the visible 
spectrum at 50 nm intervals. Data was compiled and analyzed in Excel. 
6.2.4. Scanning Electron Microscopy 
AMC vitrigels were fixed with 4% PFA, gradually dehydrate with 30%-100% ethanol, and dried 
with HMDS overnight. Samples were sputter coated with 20 nm AuPd and imaged with Leo 
FESEM.  
6.2.5. Tensile Testing 
A Bose EnduraTEC ELF3200 (Bose ElectroForce, Framingham, MA, USA) was to determine the 
stress-strain behavior of AMC materials. Samples (n=6 for each group) were cut in 5mm strips, and 
sample width and thickness was measured. The AMC materials were affixed using super glue and 
sandpaper to prevent slippage. Load /displacement measurements were recorded and analyzed.  
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6.2.6. Ex vivo migration model for tracking corneal reepithelialization 
Implants of 6 mm diameter were surgically inserted into an ex vivo cornea after creation of a partial 
pocket model with a 4-mm anterior wound. The corneas with the implants were then cultured in 
full media (DMEM + 10% FBS) up to 72 hours and reepithelialization and epithelial cell maturation 
was tracked. Reepithelialization was tracked using fluorescein dye stain.  
6.2.7. In vivo experiments 
New Zealand white rabbits were used for surgery. Under general anesthesia with Ketamine 
(35mg/kg of body weight) and Xylazine (5mg/kg of body weight) administered intramuscularly, 
partial keratectomy was conducted. After applying one to two drops of topical anesthetic 
(Proparacaine drops) the cornea was scored for a depth of about 150μm using a 6 mm Hessburg-
Barron vacuum trephine. The corneal button was removed using an ophthalmic crescent knife, 
following which, oversize implants (6.5 mm) of AMC vitrigels were carefully placed on the 
wounded cornea. The thickness of the corneal wound depth was closely matched to material 
thickness. 4 overlay sutures were used to secure materials in place using 10-0 nylon sutures. After 
surgery, atropine drops were applied once a day or every other day for five days depending on the 
amount of iris dilation to prevent cycloplegia. A mixture of anti-biotics and anti-inflammatory 
ointment was applied to the operated eye once daily for 14 days, and once every 36 hours till day 
21. Additionally, to reduce the pain, systemic analgesic (Meloxicam) was applied for 3 days via 
intramuscularly. Ophthalmic examinations were conducted at 3 days, 1 and 2 weeks post-surgery. 
To evaluate the functional re-epithelialization, 0.05% fluorescein dye was applied under blue light 
at day 7, 14, 21, and 30-day time points. Following the 31-day time-point, the animal was sacrificed, 




Following fixation in 10% Formalin, samples underwent standard graded dehydration procedure in 
ethanol, followed by xylene treatment. After overnight paraffin infiltration, samples were 
embedded in paraffin wax and sectioned using a microtome at 5 um thickness. Slides were treated 
for Hematoxylin and Eosin staining as well as Masson’s Trichrome staining. 
6.3. Results and Discussion 
6.3.1. Using ammonia to modulate collagen fibrillogenesis  
Collagen at acidic pH and at low temperatures is relatively stable as an aqueous solution. The 
temperature and pH of collagen can be gently raised in order to initiate gelation. The lab setup used 
to create the AMC gels reproducibly (Figure 6.1) consists of a water bath to control the temperature 
of ammonium hydroxide (thereby enabling the control of ammonia release) and a closed sealer 
container wherein the collagen solution was exposed to the high pH ammonia vapors for a 
stipulated time. Following gelation in the sealed chamber, the gels are then vitrified and rehydrated 
as per standard procedure (Figure 6.1B), to increase collagen concentration and create strong and 
transparent membranes (Figure 6.1C). 
6.3.2. Type I Collagen source and processing affect AMC vitrigel characteristics 
AMC gels were prepared from type I collagen extracted from human neonatal fibroblast cell-culture 
ECM (Vitrocol), rat tail tendon (Gibco) and native bovine dermis (CosmoBio). It was observed that 
the AMC vitrigels prepared from bovine collagen had greater transparency than human and rat 
collagen AMC vitrigels (Figure 6.2a). AMCs formed using human collagen Vitrocol were 
mechanically the weakest and thinnest and handling with forceps caused material disintegration.  
The relative increase in transparency and mechanical strength of bovine collagens could be 
attributed to the higher number of aromatic groups (Phe and Tyr) in bovine collagen as compared 
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to human and rat collagens. Since human and rat tail collagens were pepsin solubilized, they do not 
possess telopeptides. It can be expected that presence of the telopeptide in bovine collagen allowed 
the formation of a more robust gel. AMC vitrigels from different sources however did not 
demonstrate a large difference in thermal denaturation peaks (Figure 6.2b) indicating that the 
collagen fibril formation between the different groups is not dissimilar. 
6.3.3. Evidence of layering and alignment using Second Harmonic Generation 
microscopy 
Given this preliminary data, bovine collagen was chosen for the next experiments. AMC gels with 
bovine collagen were allowed to be in contact with ammonia gas for varying amounts of time. The 
duration of ammonia exposure significantly affects the properties of the final material. This was 
observed using Second Harmonic Generation microscopy (Figure 6.3a). Fibrillar collagen has a 
highly crystalline triple-helical structures which generate the second harmonic of incident light. 
Therefore, SHG microscopy is now widely used to detect the fibrillar structures of collagen in vitro 
or in vivo. In this study, SHG revealed the differences in fibrillogenesis of AMC vitrigels that 
exposed to Ammonia for different time duration. With short ammonia exposure time of 3 min 
(A3G30), fibrillogenesis occurred merely on the top and bottom surfaces of the membrane with 
over 150 µm in thickness. Thick fibrils scattered on the top and bottom surface, no SHG signal was 
detected in the middle of the membrane according to the Z-stack images. As the exposure time 
increases to 30 min (A3G30) and 120 min (A2hG30), more collagen fibrils with SHG signal 
appeared while fewer thick fibrils were observed as compared to the A3G30 group. 
The transparency of the vitrigels correspond to degree of fibrillogenesis. AMC vitrigels were 
prepared at physiologically relevant thicknesses, and measured using a microplate reader. 
Transparency of the AMC gels decreased with increased ammonia gelation time (Figure 6.3b).  
Gels in contact with ammonia for 3 minutes were more transparent than gels exposed to ammonia 
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for 2 hours after vitrification and rehydration. AMC vitrigels were observed to demonstrate very 
low light scattering as observed from gross pictures after vitrification (Figure 6.1c). It was 
observed that the AMC vitrigels demonstrated excellent transparency over the range of the 
spectrum.  
6.3.4. Ultrastructural and mechanical characterization  
AMC materials were also imaged using the SEM to ascertain surface topography. As initial SHG 
results implied, AMC demonstrated consistent and uniform fibrils with the characteristic d-banding 
(Figure 6.4a).  The top view of the AMC vitrigels shown demonstrate that the materials have a 
relatively smooth surface with “star shaped” self-assembled collagen bundles. As the gelation time 
increases, a larger number of mature collagen bundles were observed. Small sized collagen fibrils 
are distributed underneath the thick collagen bundles on the surface. Longer gelation time 
corresponds to assembly of thinner fibrils into thicker fibers. These findings demonstrate that 
within a defined surface area (in our case, a 35mm petri dish) and volume (5ml), ammonia exposure 
duration can be used as a measure to directly influence the collagen fibril structure. The differences 
observed in the fibrillar diameter and density may also affect macroscopic properties such as 
mechanical strength. 
In order to determine the mechanical characteristics of AMC vitrigels, tensile testing was 
performed. AMC vitrigels were rehydrated and cut into standard size test coupons and subjected to 
uniaxial tensile force. It was observed that there were no significant differences between the 
Young’s moduli of the vitrigels regardless of exposure time (Figure 6.4b), although they were 
consistently higher than a cornea control. Young’s moduli of these membranes were seen to be in 
the same range as of the previous βCD materials that the lab has produced. Further, the strain at 
break values for all samples (Figure 6.4b, c) also remained nearly constant at around 45% 
elongation, notably much lower than that of native corneal tissue.  
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6.3.5. Preliminary development of an ex vivo model for corneal reepithelialization 
In order to assess the reepithelialization potential of materials using a fast and reliable procedure 
as a first step, before in vivo animal implantation, we created and optimized an ex vivo cornea 
culture protocol. Implants of 6 mm diameter were surgically inserted into an ex vivo cornea after 
creation of a partial pocket model with a 4-mm anterior wound (Figure 6.5a). The corneas with the 
implants were then cultured in full media (DMEM + 10% FBS) up to 72 hours and 
reepithelialization and epithelial cell maturation was tracked. Reepithelialization was tracked using 
fluorescein dye stain (Figure 6.5b). Full reepithelialization in AMC materials was observed within 
72 hours, significantly faster than in the negative control implant material (chemically crosslinked 
collagen gels which have been previously tested in vivo and failed to reepithelialize). 
Epithelialization over the AMC implants, while retarded epithelialization in a material that does 
not work in vivo, is a promising sign for the validity of the experiment.  
Histological sections of the AMC implants in the ex vivo culture (Figure 6.6a) also demonstrated 
full reepithelialization in full medium within the first 48 hours, as evidenced from previous studies. 
Healthy cell layer attachment to the AMC implants was observed and multilayered cell growth over 
the implant was observed by 48 hours. At 72 hours, characteristic squamous epithelial cell 
morphology was seen on AMC materials.  
We further studied the maturation of epithelial cells on AMC materials in the ex vivo culture over 
time with immunofluorescence. Epithelial gene marker keratin 14 (K14) and tight junction protein 
ZO-1 were counterstained with DAPI on reepithelialized implants (Figure 6.6b). Marker 
expression following 24 hour in culture was relatively dim, indicating low maturation. Marker 
expression significantly improved at 48 hours and 72 hours of culture, where the epithelial cell 
layers expressed high levels of K14 and form uniform polygonal tight junctions observed via 
localized ZO-1 expression. These results indicate the AMC material not only supports epithelial 
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cell migration, but also support relatively fast maturation and differentiation. The merged images 
with DAPI, K14 and ZO-1 staining demonstrated cell maturation and marker expression on the 
AMC materials in ex vivo model. Negative control demonstrated incomplete coverage, with very 
low cell numbers, and inconsistent cell marker expression. 
6.3.6. Guiding collagen fibrillogenesis via physical nucleation cues 
AMC materials were manufactured with liquid collagen in contact with a micropatterned mesh 
(Figure 6.7a) to initiate guided collagen fibril assembly. Fibrils formed in the collagen materials 
when in contact with micropatterns were observed via SHG microscopy (Figure 6.7b) and were 
observed to closely follow the pattern. Further, we studied the impact of fibrillar patterns and 
surface morphology on epithelial cell migration. Epithelial cell marker K14 and tight junction 
protein ZO-1 were stained to test the maturation of epithelial cells (Figure 6.7c). Cells tended to 
migrate along the pattern first, and then proliferate to cover the rest of the surface. Therefore, while 
cells can be patterned by simply modulating the underlying collagen fibril pattern, the migration 
rate itself was slower than a randomized fibril surface. The immunostaining demonstrated cells 
expressed K14 epithelial marker indicating the epithelial cells maintained the phenotype, however 
due to the surface geometry, very limited ZO-1 expression was observed. These results indicate 
that a relatively smooth surface is critical for tight junction formation. 
6.3.7. In vivo surgical implantation of AMC material 
Curved AMC vitrigels were formulated using custom PDMS molds for in vivo use to determine 
epithelial migration and functional biocompatibility (Figure 6.8a). The implants were followed to 
assess degradation and epithelial migration (Figure 6.8b). The implants did not demonstrate any 
degradation, melting or related immune reactions. At day 14, AMC material demonstrated good 
attachment to host tissue. By day 31, full reepithelialization and stabilization of the implant was 
observed, accompanied by significant smoothening of the surface of the corneal wound and implant 
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region. Histological processing using Masson’s Trichrome demonstrates full epithelial coverage, 
rapid implant integration and keratocyte infiltration. Further, immunofluorescence to assess 
epithelial layer basement membrane protein Laminin expression was performed on histological 
sections. Laminin expression was evident between the epithelium and implant. The high level of 
integration and relatively quick epithelial cell migration over the AMC surface is a positive 
indicator for success in future animal trials. 
6.4. Conclusions 
The new ammonia based method of manufacturing vitrigels demonstrates great potential in terms 
of increased surface smoothness, increased optical clarity and decreased light scattering as well as 
biological and functional compatibility. The production of AMC vitrigels through varying degrees 
of exposure to ammonia demonstrates that the collagen ultrastructure of vitrigels is tunable. Further, 
bulk material properties such as transparency can be modulated by changing the underlying 
ultrastructure achieved through the versatility of the gelation process involving ammonia exposure. 
AMC materials also demonstrate biocompatibility through ex vivo studies. The ex vivo corneal 
tissue culture model demonstrated that it mimics the in vivo wound healing process and confirmed 
the viability of its results through the negative control study. This biological model allows for a 
cheaper, faster and more physiological evaluation of biocompatibility of corneal substitutes than a 
simple in vitro cell culture or scratch migration testing. Moreover, the use of the novel ex vivo 
model will enable evaluation of reepithelialization mechanisms and wound healing processes prior 
to animal testing. Finally, the suturability, biocompatibility and integration of AMC with host 
corneas in vivo was also demonstrated. Therefore, the AMC materials could potentially aid in 






Figure 6.1 Schematics depicting ammonia mediated collagen gelation. a) Laboratory setup for controlled 
ammonia exposure on collagen materials. b) Fibril formation during ammonia penetration and gelation 







Figure 6.2 AMC vitrigel formulations with different collagen sources demonstrate differences in 
physical characteristics. a) Transparency of collagen vitrigels from different collagen sources, b) 





Figure 6.3 Duration of ammonia exposure causes changes in ultrastructure and optical characteristics 
of AMC materials. a) Second harmonic generation microscopy Z-stack imaging of AMC vitrigels with 
different exposure times, b) Transparency of AMC vitrigels change dramatically with different durations of 






Figure 6.4 Ultrastructural changes and tensile properties of AMC with varying exposure times. a) SEM 
images of AMC vitrigels demonstrating fibrillar surface topography, b) Young’s modulus and Strain at Break 






Figure 6.5 Development of ex vivo culture model for tracking corneal reepithelialization. a) Schematic 
depicting ex vivo corneal surgery and implantation of AMC materials, b) Fluorescein dye staining and 






Figure 6.6 Histology and immunofluorescence of ex vivo AMC corneal cultures. a) H&E staining of 
corneal sections to demonstrate multicellular epithelialization, b) Immunofluorescence marker expression 
for nucleus (DAPI), keratin-14 (K14) and tight junction protein (ZO-1) in AMC materials to track epithelial 
cell maturation over 24 h, 48 hand 72 h. 




Figure 6.7 Micropatterning collagen ultrastructures on AMC materials. a) Micropattern mesh used to 
initiate guided fibril formation, b) SHG imaging of micropatterned AMC materials to visualize collagen fibril 
formation patterns, c) Corneal epithelial cell maturation with immunofluorescence markers K14, ZO-1 and 






Figure 6.8 In vivo implantation of AMC vitrigels in rabbit model. a) Custom-made PDMS molds to 
manufacture lenticular AMC materials, b) Implanted AMC materials tracked over 31 days via anterior 
lamellar keratoplasty through gross images and fluorescein staining, c) Masson’s Trichrome histology to 
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